DE102006047732A1 - Means for the treatment of blond or bleached hair - Google Patents

Abstract

The invention relates to keratin fiber treatment compositions, in particular hair treatment compositions, containing - based on its weight - 0.0005 to 5 wt .-% of one or more complexing agents from the groups of esters of citric acid and / or esters of salicylic acid and / or aminopolycarboxylic acids and / or the phosphonates and / or phosphates and / or the gluconates and / or the nitriloacetic acid and its salts, the use of this agent for the treatment of a particular greenish-stained discoloration of blond or bleached hair, and a method for treating in particular greenish discoloration of blonde or blond hair.

Description

The The present invention relates to agents for coloring and / or lightening keratinic Fibers, i. Agent for use on keratin fibers, in particular human hair, and their use. In particular, it concerns the invention keratin fiber treatment agent, in particular hair treatment agent, containing one or more specific complexing agents, the use this agent for the treatment of a particular green-stichigen discoloration blond or bleached hair and a procedure for treatment especially greenish-stingy discoloration blond or blond hair.

The Cosmetic treatment of skin and hair is an important part of human body care. Thus, human hair is today in many ways with hair cosmetic Treated preparations. These include cleaning the Hair with shampoos, care and regeneration with rinses and Cures and bleaching, dyeing and deforming the hair with colorants, Tints, Waving and styling agents. There are funds for change or nuancing the color of the head hair a prominent role. You can serve the natural Hair color according to the wishes and Needs of the slightly or more closely to the corresponding person, a completely different one To achieve hair color or unwanted shades, like gray tones, to cover. In addition to coloring and sounds is the oxidative lightening of the hair by breaking down natural Hair dyes, the melanin pigments, an important aspect in the Range of hair coloring Cosmetics. In the case of a dark hair color, Eumelanine and Pfäomelanine, in light or reddish Hair essentially Pfäomelanine be reduced. The basics of the Blondierverfahren are the expert known and can in relevant Monographs be read.

Blondierungen usually sit down composed of two parts, a solid oxidizing agent (bleaching agent) and more dilute Hydrogen peroxide solution, immediately before use to a solid or paste-like preparation be mixed. This mixture is then applied to the hair and rinsed out again after a certain exposure time.

Next The degradation of the melanin pigments are also bleached by bleaching Polypeptide chains of the hair attacked. The blond hair is rougher, brittle and more porous and thus more sensitive to environmental influences. The absorbency the hair keratin bleached hair is increased. Comes blond hair In contact with copper ions, they are absorbed by the hair. It forms a blue copper-protein complex that often with slightly yellowish, bleached hair gives the mixed color green.

Also unbleached hair can Copper ions absorb the absorbency of undyed hair but is a little lower. In natural dark hair falls a possible Copper ion absorption does not color up. With natural blonde Hair, on the other hand, leads a copper ion absorption also to a greener.

copper ions occur, for example, in tap water when used for its supply copper pipes or in swimming pools, in which copper sulfide is used as algicide. The hair may e.g. while bathing in swimming pools or when washing hair with water flowing through copper pipes, with Copper ions come into contact.

Out the prior art are various products for treatment an undesirable Green color of blond or bleached hair known. These include e.g. Citric acid or Complexing agents, e.g. EDTA or iminodisuccinic acid, containing Products.

These Solution approaches The prior art can partly from the point of view of effectiveness, partly off cost reasons or from ecological Aspects are not completely convincing.

It It was therefore an object of the present invention to provide a means when applied to discolored, especially green-colored, blond or bleached hair has an improved decolorizing ability, wherein the ingredients used ecologically (biodegradability) and economically (Raw material costs) are optimized. In addition, should also be a treatment be made possible by dull, dull, dull hair, by the Treatment regain shine and radiant colors.

A further object of the present invention was to improve the care performance of hair treatment compositions for discoloring discolored, in particular green-discolored, blond or bleached hair. Usually means for deep cleansing are formulated rich in surfactants, in order to stand in the foreground the cleaning success, at which the consumer measures the product performance, to be as high as possible. However, the surfactant-rich formulation burdened by their strong degreasing effect, the hair structure, so that the hair is cleaned well with conventional means and freed from greenish discoloration, but the care of the hair is not sufficiently guaranteed even with the addition of care.

A Another object of the invention, therefore, was to provide means the a high cleaning success with excellent protection and Care of the hair connect. In particular, the agents according to the invention should with high cleaning performance also formulated with low surfactant or even tensi-free can be.

It it has now been found that incorporate certain complexing agents into hair treatment products, and thus also at low surfactant contents a high cleaning performance the agent is effected. Optionally used care substances can do so to best advantage.

The present invention is in a first embodiment, an agent for the treatment of keratinous fibers, in particular human hair, having a pH of 2 to 5, preferably from 3 to 4, containing - based on its weight - 0.0005 to 5 wt. % of one or more complexing agents from the groups of
Esters of citric acid,
Esters of salicylic acid,
aminopolycarboxylic acids,
Phosphonates and / or phosphates,
Gluconate
Nitriloacetic acid and its salts.

Under Keratin fibers are furs, wool, feathers and especially human ones To understand hair. Although the agents of the invention in the first place to dye and / or whitening keratin fibers is suitable in principle their use in other areas.

The keratinous fiber treatment agent according to the invention, especially hair treatment agents, can in conventional dosage forms, such as. as a cream, lotion, solution, Water, emulsion, microemulsion, gel, spray, aerosol and foam aerosol be applied on the hair.

The agents according to the invention Contained as essential ingredient - by weight - 0.0005 to 5 wt .-% of at least one complexing agent from the above. Groups. These are described below.

a) Citric acid ester:

As a tri-protic acid, citric acid forms three series of esters, the mono-, di-, and triesters. Although all citric acid esters can be used according to the invention, the triesters are preferred according to the invention. For cost reasons, among these, the non-mixed triesters are preferred because esters having different alcohol radicals on different carboxyl groups are more synthetically expensive. Citric acid esters which can preferably be used in accordance with the invention are trimethyl citrate (trimethyl citric acid), triethyl citrate (triethyl citrate), tripropyl citrate (triplicate citric acid), triisopropyl citrate (triisopropyl citrate), tri (n-butyl) citrate (tri (n-butyl) citric acid), trilsobutyl citrate (trilsobutyl citrate), tri (sec Butyl) citrate (sec-butyl), tri (tert-butyl) citrate (tri (tert-butyl) citric acid), tri (n-pentyl) citrate (citric acid tri (n-pentyl) ester), tri (tri (tert-butyl) citrate) n-hexyl) citrate (tri (n-hexyl) citrate), tri (n-heptyl) citrate (tri (n-heptyl) citrate), tri (n-octyl) citrate (tri (n-octyl) citric acid), tri (n-nonyl) citrate tri (n-nonyl) ester, tri (n-decyl) citrate tri (n-decyl) ester, tri (n-undecyl) citrate tri (n-undecyl) citrate, Tri (n-dodecyl) citrate (citric acid tri (n-dodecyl) ester). The OH group of citric acid can optionally be etherified or esterified. Corresponding compounds which can also be used according to the invention are, for example, trimethyl acetyl citrate (trimethyl acetylcitric acidate), triethyl acetyl citrate (triethyl acetylcitric acid ester), tripropyl acetyl citrate (tri-propyl acetylcitric acid ester), triisopropyl acetyl citrate (triisopropyl acetylcitric acid ester), tri (n-butyl) acetyl citrate (triethyl acetylcitric acid), trilsobutyl acetyl citrate ( Tris (sec-butyl) acetyl citrate (sec-butyl acetylcitric acid), tri (tert-butyl) acetyl citrate (tri (tert-butyl acetylcitric acid) ester), tri (n-pentyl) acetyl citrate (acetylcitric acid tri (n-pentyl tri (n-hexyl) acetyl citrate (acetylcitric acid tri (n-hexyl) ester), tri (n-heptyl) acetyl citrate (acetylcitric acid tri (n-heptyl) ester), tri (n-octyl) acetyl citrate (acetylcitric acid tri (n-hexyl) Octyl) ester), tri (n-nonyl) acetylcitrate (acetylcitric acid tri (n-nonyl) ester), tri (n-decyl) acetyl citrate (acetylcitric acid tri (n-decyl) ester), tri (n-undecyl) acetyl citrate (acetylcitric acid tri (n-undecyl) ester), tri (n-dodecyl) acetyl citrate (Acetylcitronensäuretri (n-dodecyl) ester).

b) esters of salicylic acid,

According to the invention preferred Compounds from this group are salicylic acid methyl ester, salicylic acid ethyl ester, Salicylsäurepropylester, Salicylsäureisopropylester, Salicylic acid (n-butyl) ester, salicylic acid-butyl ester, Salicylic acid (sec-butyl) ester, Salicylic acid (tert-butyl) ester, Salicylic acid (n-pentyl) ester, Salicylic acid (n-hexyl) ester, Salicylic acid (n-heptyl) ester, salicylic acid (n-octyl) ester, Salicylic acid (n-nonyl) ester, Salicylic acid (n-decyl) ester, Salicylic acid (n-undecyl) ester, salicylic acid (n-dodecyl) ester.

The OH group of salicylic acid may optionally be etherified or esterified. Appropriate Compounds which can likewise be used according to the invention are, for example acetylsalicyl, Acetylsalicylsäureethylester, Acetylsalicylsäurepropylester, Acetylsalicylsäureisopropylester, Acetylsalicylic acid (n-butyl) ester, Acetylsalicylsäureisobutylester, Acetylsalicylic acid (sec-butyl) ester, Acetylsalicylic acid (tert-butyl) ester, Acetylsalicylic acid (n-pentyl) ester, Acetylsalicylic acid (n-hexyl) ester, Acetylsalicylic acid (n-heptyl) ester, Acetylsalicylic acid (n-octyl) ester, Acetylsalicylic acid (n-nonyl) ester, acetylsalicylic acid (n-decyl) ester, Acetylsalicylic acid (n-undecyl) ester, Acetylsalicylic acid (n-dodecyl) ester.

c) aminopolycarboxylic acids,

In the group of aminopolycarboxylic acids For example, ethylenediaminetetraacetic acid (EDTA) and nitrilotriacetic acid (NTA) are included. and their salts. These compounds are less according to the invention prefers.

According to the invention preferred aminopolycarboxylic are, for example, diethylenetriaminepentaacetic acid (DTPA), β-alaninediacetic acid (β-ADA), 1,3-propylenediaminetetraacetic acid (1,3-PDTA) and methylglycinediacetic acid (MGDA). Overall, aminopolycarboxylic acids according to the invention over the Complexing agents from the other groups less preferred.

d) phosphonates and / or phosphates,

Phosphates are the salts and esters of ortho-phosphoric acid. Phosphonates are salts and esters of phosphonic acid. As salts exist primary (M'H ₂ PO ₃ ) and secondary (M ' ₂ HPO ₃ ) phosphonates. (M ': monovalent metal). Practically important are the esters of this group of substances. Phosphonates differ from esters of phosphates in their direct binding of phosphorus with carbon (CP bond). Phosphates have COP bonds. The latter are easy to hydrolyze. CP bonds are usually more stable. Preferred compounds of this class according to the invention are, for example, 1-hydroxyethane- (1,1-diphosphonic acid) (HEDP), aminotrimethylenephosphonic acid or amino-tris (methylenephosphonic acid), identical to NTMP, Nitrolotris (methylenephosphonic acid) (ATMP, NTMP), diethylenetriaminepenta (methylenephosphonic acid ) or diethylenetriamine penta (methylenephosphonic acid) (DTPMP) and ethylenediaminetetra (methylenephosphonic acid) or ethylenediaminetetra (methylenephosphonic acid) (EDTMP).

e) gluconates

Gluconic acid is a carboxylic acid and heard to the group of fruit acids. In the classification of compounds derived from carbohydrates she is in the group of on acids classified. Their salts can find use as complexing agents. According to the invention preferred are sodium gluconate, potassium gluconate, ammonium gluconate, zinc gluconate.

f) nitriloacetic acid and its salts.

Usable according to the invention is also the nitriloacetic acid N = C-OOOH (oxalic acid mononitrile, "cyanocarbonic acid", Chemical Abstracts: Carbonocyanidsäure) also in the form of their salts. Prefabricated compounds according to the invention next to the pure acid the sodium, potassium, ammonium or zinc salts of nitrile acetic acid.

In summary, preferred agents according to the invention are characterized in that they contain from 0.001 to 4% by weight, preferably from 0.01 to 3% by weight, particularly preferably from 0.1 to 2.5% by weight, more preferably from 0.2 to 2 Wt .-% and in particular 0.25 to 1.5 wt .-% of at least one complexing agent from the group
Citric acid trimethyl ester and / or
Citric acid triethyl ester and / or
Citric acid tripropyl esters and / or
Citric acid triisopropyl ester and / or
Salicylic acid methyl ester and / or
Salicylic acid ethyl ester and / or
Salicylic acid propyl ester and / or
Salicylic acid isopropyl ester and / or
Nitrilotriacetic acid and / or
Nitrilotriacetic acid trisodium salt and / or
Nitrilotriacetic acid tripotassium salt and / or
Nitrilotriacetic acid triammonium salt and / or
Diethylenetriamine pentaacetic acid (DTPA) and / or
β-alaninediacetic acid (β-ADA) and / or
1,3-propylenediaminetetraacetic acid (1,3-PDTA) and / or
Methylglycinediacetic acid (MGDA) and / or
Nitriloacetic acid and / or
Nitriloacetic acid sodium salt and / or
Nitriloacetic acid potassium salt and / or
Nitriloacetic acid ammonium salt
contain.

The agents according to the invention have a pH of 2 to 5. Preferred agents have pH values from 2.5 to 4.5, particularly preferred means such from 3 to 4.

When another optional ingredient may be the agents of the invention 0.01 to 10 wt .-% of at least one polymer from the group of cationic and / or amphoteric polymers.

Under cationic or amphoteric polymers are polymers, which have a group in the main and / or side chain, which are "temporary" or "permanent" cationic can. As "permanent cationic " According to the invention such Polymers referred to independently have a cationic group from the pH of the agent. This are usually polymers containing a quaternary nitrogen atom, for example in the form of an ammonium group. Preferred cationic Groups are quaternary Ammonium groups. In particular, such polymers in which the quaternary ammonium group via a C1-4 hydrocarbon group to one of acrylic acid, methacrylic acid or whose derivatives are attached to a polymer backbone, have proven to be particularly suitable.

In addition to cationic polymers or in their place, the agents according to the invention also contain amphoteric polymers. These additionally have at least one negative charged group in the molecule and are also referred to as zwitterionic polymers.

Preferably the polymer (s) will be within narrower ranges used. Thus, agents according to the invention are preferred which are based on on her weight - 0.05 to 7.5% by weight, preferably 0.1 to 5% by weight, more preferably 0.2 to 3.5% by weight and in particular 0.25 to 2.5% by weight amphoteric (s) Polymer (s) included.

Independently of, whether the agents contain amphoteric polymers or not, further preferred agents according to the invention are characterized in that that they - related on her weight - 0.05 to 7.5% by weight, preferably 0.1 to 5% by weight, more preferably 0.2 to 3.5% by weight and in particular 0.25 to 2.5% by weight cationic (s) Polymer (s) included.

in der R¹= -H oder -CH₃ ist, R², R³ und R⁴ unabhängig voneinander ausgewählt sind aus C1-4-Alkyl-, -Alkenyl- oder -Hydroxyalkylgruppen, m = 1, 2, 3 oder 4, n eine natürliche Zahl und X^- ein physiologisch verträgliches organisches oder anorganisches Anion ist, sowie Copolymere, bestehend im wesentlichen aus den in Formel (G1-I) aufgeführten Monomereinheiten sowie nichtionogenen Monomereinheiten, sind besonders bevorzugte kationische Polymere. Im Rahmen dieser Polymere sind diejenigen erfindungsgemäß bevorzugt, für die mindestens eine der folgenden Bedingungen gilt:

• – R¹ steht für eine Methylgruppe
• – R², R³ und R⁴ stehen für Methylgruppen
• – m hat den Wert 2.

Cationic polymers which can preferably be used according to the invention are described below:
Homopolymers of the general formula (G1-I),

in which R ¹ = -H or -CH ₃ , R ² , R ³ and R ^{4 are} independently selected from C 1-4 -alkyl, -alkenyl or -hydroxyalkyl groups, m = 1, 2, 3 or 4, n is a natural number and X ^{- is} a physiologically acceptable organic or inorganic anion, as well as copolymers consisting essentially of the monomer units listed in formula (G1-I) and nonionic monomer units, are particularly preferred cationic polymers. In the context of these polymers, preference is given to those according to the invention for which at least one of the following conditions applies:

• - R ¹ is a methyl group
• - R ² , R ³ and R ⁴ are methyl groups
• - m has the value 2.

Suitable physiologically tolerated counterions X ^- include, for example, halide ions, sulfate ions, phosphate ions, methosulfate ions and organic ions such as lactate, citrate, tartrate and acetate ions. Preference is given to halide ions, in particular chloride.

A particularly suitable homopolymer is, if desired, crosslinked, poly (methacryloyloxyethyltrimethylammonium chloride) with the INCI name Polyquaternium-37. Such products are available, for example under the names Rheocare ^® CTH (Cosmetic Rheologies) and Synthalen® ^® CR (Ethnichem) in trade. If desired, the crosslinking can be carried out with the aid of poly olefinically unsaturated compounds, for example divinylbenzene, tetraallyloxyethane, methylenebisacrylamide, diallyl ether, polyallylpolyglyceryl ethers, or allyl ethers of sugars or sugar derivatives such as erythritol, pentaerythritol, arabitol, mannitol, sorbitol, sucrose or glucose. Methylenebisacrylamide is a preferred crosslinking agent.

The homopolymer is preferably used in the form of a nonaqueous polymer dispersion which should not have a polymer content of less than 30% by weight. Such polymer dispersions are (under the names Salcare ^® SC 95 about 50% polymer content, additional components: mineral oil (INCI name: Mineral Oil) and tridecyl-polyoxypropylene-polyoxyethylene-ether (INCI name: PPG-1 trideceth-6) ) and Salcare ^® SC 96 (about 50% polymer content, additional components: mixture of diesters of propylene glycol (with a mixture of caprylic and capric acid INCI name: propylene glycol Dicaprylate / Dicaprate) and Tridecylpolyoxypropylen polyoxyethylene ether (INCI name : PPG-1-trideceth-6)) are commercially available.

Copolymers having monomer units of the formula (G1-I) contain as nonionic monomer units preferably acrylamide, methacrylamide, acrylic acid-C _1-4 -alkyl esters and methacrylic acid-C _1-4 -alkyl esters. Among these nonionic monomers, the acrylamide is particularly preferred. These copolymers can also be crosslinked, as described above in the case of the homopolymers. A copolymer preferred according to the invention is the crosslinked acrylamide-methacryloyloxyethyltrimethylammonium chloride copolymer. Such copolymers in which the monomers are present in a weight ratio of about 20:80, are commercially available as approximately 50% non-aqueous polymer dispersion 92 under the name Salcare ^® SC.

• – quaternisierte Cellulose-Derivate, wie sie unter den Bezeichnungen Celquat^® und Polymer JR^® im Handel erhältlich sind. Die Verbindungen Celquat^® H 100, Celquat^® L 200 und Polymer JR^®400 sind bevorzugte quaternierte Cellulose-Derivate,
• – kationische Alkylpolyglycoside gemäß der DE-PS 44 13 686 ,
• – kationisierter Honig, beispielsweise das Handelsprodukt Honeyquat^® 50,
• – kationische Guar-Derivate, wie insbesondere die unter den Handelsnamen Cosmedia^®Guar und Jaguar^® vertriebenen Produkte,
• – polymere Dimethyldiallylammoniumsalze und deren Copolymere mit Estern und Amiden von Acrylsäure und Methacrylsäure. Die unter den Bezeichnungen Merquat^®100 (Poly(dimethyldiallylammoniumchlorid)) und Merquat^®550 (Dimethyldiallylammoniumchlorid-Acrylamid-Copolymer) im Handel erhältlichen Produkte sind Beispiele für solche kationischen Polymere,
• – Copolymere des Vinylpyrrolidons mit quaternierten Derivaten des Dialkylaminoalkylacrylats und -methacrylats, wie beispielsweise mit Diethylsulfat quaternierte Vinylpyrrolidon-Dimethylaminoethylmethacrylat-Copolymere. Solche Verbindungen sind unter den Bezeichnungen Gafquat^®734 und Gafquat^®755 im Handel erhältlich,
• – Vinylpyrrolidon-Vinylimidazoliummethochlorid-Copolymere, wie sie unter den Bezeichnungen Luviquat^® FC 370, FC 550, FC 905 und HM 552 angeboten werden,
• – quaternierter Polyvinylalkohol,
• – sowie die unter den Bezeichnungen Polyquaternium 2, Polyquaternium 17, Polyquaternium 18 und Polyquaternium 27 bekannten Polymeren mit quartären Stickstoffatomen in der Polymerhauptkette.

Further preferred cationic polymers are, for example

• - Quaternized cellulose derivatives, such as those under the names Celquat ^® and Polymer JR ^® commercially available. The compounds Celquat ^® H 100, Celquat L 200 and Polymer JR ^{® ®} 400 are preferred quaternized cellulose derivatives
• Cationic alkyl polyglycosides according to DE-PS 44 13 686 .
• - cationized honey, for example the commercial product Honeyquat ^® 50,
• - cationic guar derivatives, such as in particular the products sold under the trade names Cosmedia® ^® Guar and Jaguar ^®,
• - Dimethyldiallylammoniumsalze polymeric and their copolymers with esters and amides of acrylic acid and methacrylic acid. Under the names Merquat ^® 100 (Poly (dimethyldiallylammonium chloride)) and Merquat ^® 550 (dimethyldiallylammonium chloride-acrylamide copolymer) are examples of such cationic polymers,
• - Copolymers of vinylpyrrolidone with quaternized derivatives of dialkylaminoalkyl acrylate and methacrylate, such as diethyl sulfate quaternized vinylpyrrolidone-dimethylaminoethyl methacrylate copolymers. Such compounds are sold under the names Gafquat ^® 734 and Gafquat ^® 755 commercially,
• - vinylpyrrolidone vinylimidazoliummethochloride copolymers, such as those offered under the names Luviquat.RTM ^® FC 370, FC 550, FC 905 and HM 552,
• - quaternized polyvinyl alcohol,
• - as well as the polymers known under the names Polyquaternium 2, Polyquaternium 17, Polyquaternium 18 and Polyquaternium 27 with quaternary nitrogen atoms in the polymer main chain.

Can be used as cationic polymers are sold under the names Polyquaternium-24 (commercial product z. B. Quatrisoft ^® LM 200), known polymers. , Gaffix ^® VC 713 (manufactured by ISP): Also according to the invention can be used the copolymers of vinylpyrrolidone, such as the commercial products Copolymer 845 (ISP manufacturer) are Gafquat ^® ASCP 1011, Gafquat ^® HS 110, Luviquat ^® 8155 and Luviquat ^® MS 370 available are.

When cationic polymers can cationic protein hydrolysates may also be used, with preferred Means one or more cationic protein hydrolysates from the group Cocodimonium Hydroxypropyl Hydrolyzed Collagen, Cocodimonium Hydroxypropyl Hydrolyzed Casein, Cocodimonium Hydroxypropyl Hydrolyzed Collagen, Cocodimonium Hydroxypropyl Hydrolyzed Hair Keratin, Cocodimonium Hydroxypropyl Hydrolyzed Keratin, Cocodimonium Hydroxypropyl Hydrolyzed Rice Protein, Cocodimonium Hydroxypropyl Hydrolyzed Soy Protein, Cocodimonium Hydroxypropyl Hydrolyzed Wheat Protein, Hydroxypropyl Arginine Lauryl / Myristyl Ether HCl, Hydroxypropyltrimonium Gelatin, Hydroxypropyltrimonium Hydrolyzed Casein, Hydroxypropyltrimonium Hydrolyzed Collagen, Hydroxypropyltrimonium Hydrolyzed Conchiolin Protein, hydroxypropyltrimonium hydrolyzed keratin, hydroxypropyltrimonium Hydrolyzed Rice Bran Protein, Hydroxypropyltrimonium Hydrolyzed Soy Protein, Hydroxypropyl Hydrolyzed Vegetable Protein, Hydroxypropyltrimonium Hydrolyzed Wheat Protein, Hydroxypropyltrimonium Hydrolyzed Wheat Protein / Siloxysilicate, Laurdimonium Hydroxypropyl Hydrolyzed Soy Protein, Laurdimonium Hydroxypropyl Hydrolyzed Wheat Protein, Lauridimonium Hydroxypropyl Hydrolyzed Wheat Protein / Siloxysilicate, Lauryldimonium Hydroxypropyl Hydrolyzed Casein, Lauryldimonium Hydroxypropyl Hydrolyzed Collagen, Lauryldimonium Hydroxypropyl Hydrolyzed Keratin, Lauryldimonium Hydroxypropyl Hydrolyzed Soy Protein, Steardimonium Hydroxypropyl Hydrolyzed Casein, Steardimonium Hydroxypropyl Hydrolyzed Collagen, Steardimonium Hydroxypropyl Hydrolyzed Keratin, Steardimonium Hydroxypropyl Hydrolyzed Rice Protein, Steardimonium Hydroxypropyl Hydrolyzed Soy Protein, Steardimonium Hydroxypropyl Hydrolyzed Vegetable Protein, Steardimonium Hydroxypropyl Hydrolyzed Wheat Protein, Steartrimonium Hydroxyethyl Hydrolyzed Collagen, Quaternium-76 Hydrolyzed Collagen, Quaternium-79 Hydrolyzed Collagen, Quaternium-79 Hydrolyzed Keratin, Quaternium-79 Hydrolyzed Milk Protein, Quaternium-79 Hydrolyzed Soy Protein, Quaternium-79 Hydrolyzed Wheat Protein included.

In summary, agents according to the invention are preferred which, based on their weight, are 0.05 to 7.5% by weight, preferably 0.1 to 5% by weight, particularly preferably 0.2 to 3.5% by weight and in particular from 0.25 to 2.5% by weight of cationic polymer (s), preferred cationic polymer (s) being / are selected from
Poly (methacryloyloxyethyltrimethylammonium chloride) (INCI: Polyquaternium-37) and / or;
quaternized cellulose derivatives (INCI: Polyquaternium 10) and / or
cationic alkyl polyglycosides and / or
cationized honey and / or
cationic guar derivatives and / or
polymeric dimethyldiallylammonium salts and their copolymers with esters and
Amides of acrylic acid and methacrylic acid and / or
Copolymers of vinylpyrrolidone with quaternized derivatives of dialkylaminoalkyl acrylate and methacrylate and / or
Vinylpyrrolidone-Vinylimidazoliummethochlorid copolymers and / or
quaternized polyvinyl alcohol and / or
Polyquaternium 2 and / or
Polyquaternium-7 and / or
Polyquaternium 17 and / or
Polyquaternium 18 and / or
Polyquaternium 24 and / or
Polyquaternium 27
Cationic silicones, in particular amodimethicones.

The cationic silicones are described in detail below for the silicones.

• A) Monomeren mit quartären Ammoniumgruppen der allgemeinen Formel (Z-I), R¹-CH=CR²-CO-Z-(C_nH_2n)-N⁽⁺⁾R³R⁴R⁵ A^(-)( Z-I) In der R¹ und R² unabhängig voneinander stehen für Wasserstoff oder eine Methylgruppe und R³, R⁴ und R⁵ unabhängig voneinander für Alkylgruppen mit 1 bis 4 Kohlenstoff- Atomen, Z eine NH-Gruppe oder ein Sauerstoffatom, n eine ganze Zahl von 2 bis 5 und A^(-) das Anion einer organischen oder anorganischen Säure ist und
• B) monomeren Carbonsäuren der allgemeinen Formel (Z-II), R⁶-CH=CR⁷-COOH (Z-II)in denen R⁶ und R⁷ unabhängig voneinander Wasserstoff oder Methylgruppen sind.

In addition to the cationic polymers or in their place, the agents of the invention may contain amphoteric polymers. In the context of the present invention preferably usable amphoteric polymers are composed essentially together

• A) monomers having quaternary ammonium groups of the general formula (ZI), R ¹ -CH = CR ² -CO-Z- (C _n H _2n ) -N ⁽⁺⁾ R ³ R ⁴ R ⁵ A ^(-) (ZI) In the R ¹ and R ² independently of one another are hydrogen or a methyl group and R ³ , R ⁴ and R ^{5 are} independently alkyl groups having 1 to 4 carbon atoms, Z is an NH group or an oxygen atom, n is an integer of 2 to 5 and A ^{(-) is} the anion of an organic or inorganic acid and
• B) monomeric carboxylic acids of the general formula (Z-II), R ⁶ -CH = CR ⁷ -COOH (Z-II) in which R ⁶ and R ^{7 are} independently hydrogen or methyl groups.

suitable Starting monomers are z. Dimethylaminoethylacrylamide, dimethylaminoethylmethacrylamide, Dimethylaminopropylacrylamide, dimethylaminopropylmethacrylamide and Diethylaminoethylacrylamid, if Z is an NH group or Dimethylaminoethyl acrylate, dimethylaminoethyl methacrylate and diethylaminoethyl acrylate, when Z is an oxygen atom.

The a tertiary Amino-containing monomers are then in a known manner quaternized, wherein as alkylating reagents methyl chloride, dimethyl sulfate or diethyl sulfate are particularly suitable. The quaternization reaction can in aqueous solution or in the solvent respectively.

Advantageously, such monomers of formula (ZI), which are derivatives of acrylamide or methacrylamide. Preference is furthermore given to those monomers which contain halide, methoxysulfate or ethoxysulfate ions as counterions. Also preferred are those monomers of the formula (ZI) in which R ³ , R ⁴ and R ^{5 are} methyl groups.

The Acrylamidopropyltrimethylammonium chloride is a very special one preferred monomer of the formula (Z-I).

When monomeric carboxylic acids of the formula (Z-II) are acrylic acid, methacrylic acid, crotonic acid and 2-methyl-crotonic acid. Preference is given to using acrylic or methacrylic acid, in particular acrylic acid.

The can be used according to the invention zwitterionic polymers are prepared from monomers of the formulas (Z-I) and (Z-II) according to known polymerization. The polymerization can be carried out either in aqueous or aqueous-alcoholic solution respectively. Alcohols are alcohols having 1 to 4 carbon atoms, preferably isopropanol, used simultaneously as a polymerization regulator serve. The monomer solution can but other components are added as a regulator, z. B. formic acid or mercaptans, such as thioethanol and thioglycolic acid. The initiation of the polymerization takes place with the help of radical-forming substances. For this purpose, redox systems and / or thermally decomposing radical formers of the azo compound type, such as Azoisobutyronitrile, Azo-bis (cyanopentanoic acid) or azo-bis (amidinopropane) dihydrochloride be used. As redox systems are z. B. Combinations from hydrogen peroxide, potassium or ammonium peroxodisulfate as well tertiary Butyl hydroperoxide with sodium sulfite, sodium dithionite or hydroxylamine hydrochloride as a reduction component.

The Polymerization may be isothermal or under adiabatic conditions carried out be, depending on from the concentration ratios by the released heat of polymerization of the temperature range for the process the reaction between 20 and 200 ° C may vary, and the reaction optionally under the autogenous overpressure carried out must become. Preferably, the reaction temperature is between 20 and 100 ° C.

Of the pH during The copolymerization can vary within a wide range. advantageously, is polymerized at low pHs; however, pH values above the Neutral point. After the polymerization is carried out with an aqueous base, z. As sodium hydroxide, potassium hydroxide or ammonia, to a pH between 5 and 10, preferably 6 to 8, set. Details of the polymerization process can taken from the examples.

When Such polymers have proven particularly effective in which the monomers of the formula (Z-I) over the monomers of the formula (Z-II) in excess. It is therefore preferred according to the invention to use those polymers which consist of monomers of the formula (Z-I) and the monomers of the formula (Z-II) in a molar ratio of 60:40 to 95: 5, especially from 75:25 to 95: 5 exist.

• A) Monomeren mit quartären Ammoniumgruppen der allgemeinen Formel (Z-I), R¹-CH=CR²-CO-Z-(C_nH_2n)-N⁽⁺⁾R³R⁴R⁵ A^(-) (Z-I)in der R¹ und R² unabhängig voneinander stehen für Wasserstoff oder eine Methylgruppe und R³, R⁴ und R⁵ unabhängig voneinander für Alkylgruppen mit 1 bis 4 Kohlenstoff-Atomen, Z eine NH-Gruppe oder ein Sauerstoffatom, n eine ganze Zahl von 2 bis 5 und A^{( - )} das Anion einer organischen oder anorganischen Säure ist und
• B) monomeren Carbonsäuren der allgemeinen Formel (Z-II), R⁶-CH=CR⁷-COOH (Z-II)in der R⁶ und R⁷ unabhängig voneinander Wasserstoff oder Methylgruppen sind.

Agents preferred according to the invention are characterized in that the amphoteric polymer (s) comprise monomers A) and B), wherein A) and B) are selected from

• A) monomers having quaternary ammonium groups of the general formula (ZI), R ¹ -CH = CR ² -CO-Z- (C _n H _2n ) -N ⁽⁺⁾ R ³ R ⁴ R ⁵ A ^(-) (ZI) in which R ¹ and R ² independently of one another are hydrogen or a methyl group and R ³ , R ⁴ and R ⁵ are each independently alkyl groups having 1 to 4 carbon atoms, Z is an NH group or an oxygen atom, n is an integer of 2 to 5 and A ^{( - ) is} the anion of an organic or inorganic acid and
• B) monomeric carboxylic acids of the general formula (Z-II), R ⁶ -CH = CR ⁷ -COOH (Z-II) in which R ⁶ and R ^{7 are} independently hydrogen or methyl groups.

With particular advantage contained in the compositions of the invention used amphoteric polymers monomers from the group of acrylamides and / or methacrylamides with alkylammonium groups. As additional in have monomers with anionic groups contained in the polymers acrylic acid and / or methacrylic acid and / or crotonic acid and / or 2-methyl crotonic acid proven.

• – Trimethylammoniumethylacrylamid und/oder,
• – Trimethylammoniumethylmethacrylamid und/oder
• – Trimethylammoniumpropylacrylamid und/oder
• – Trimethylammoniumpropylmethacrylamid und/oder
• – Trimethylammoniumethylacrylamid und/oder
• – Trimethylammoniumethylacrylat und/oder
• – Trimethylammoniumethylmethacrylat und/oder
• – Trimethylammoniumethylacrylat und/oder
• – Ethyldimethylammoniumethylacrylamid und/oder,
• – Ethyldimethylammoniumethylmethacrylamid und/oder
• – Ethyldimethylammoniumpropylacrylamid und/oder
• – Ethyldimethylammoniumpropylmethacrylamid und/oder
• – Ethyldimethylammoniumethylacrylamid und/oder
• – Ethyldimethylammoniumethylacrylat und/oder
• – Ethyldimethylammoniumethylmethacrylat und/oder
• – Ethyldimethylammoniumethylacrylat mit mindetsnes einem der Monomere
• – Acrylsäure und/oder
• – Methacrylsäure und/oder
• – Crotonsäure und/oder
• – 2-Methyl-crotonsäure

sind.In summary, agents according to the invention are preferred in which the amphoteric polymer (s) are co-polymers of at least one of the monomers

• Trimethylammoniumethylacrylamide and / or
• - Trimethylammoniumethylmethacrylamid and / or
• - trimethylammoniumpropylacrylamide and / or
• - Trimethylammoniumpropylmethacrylamid and / or
• - Trimethylammoniumethylacrylamid and / or
• - Trimethylammoniumethylacrylat and / or
• - Trimethylammoniumethylmethacrylat and / or
• - Trimethylammoniumethylacrylat and / or
• Ethyldimethylammoniumethylacrylamide and / or
• - Ethyldimethylammoniumethylmethacrylamid and / or
• Ethyldimethylammoniumpropylacrylamide and / or
• Ethyldimethylammoniumpropylmethacrylamide and / or
• - Ethyldimethylammoniumethylacrylamid and / or
• - Ethyldimethylammoniumethylacrylat and / or
• - Ethyldimethylammoniumethylmethacrylat and / or
• - Ethyldimethylammoniumethylacrylat with mindetsnes one of the monomers
• - acrylic acid and / or
• - methacrylic acid and / or
• - Crotonic acid and / or
• - 2-methyl-crotonic acid

are.

• – Copolymere von Trimethylammoniumethylacrylamid mit Acrylsäure
• – Copolymere von Trimethylammoniumethylacrylamid mit Methacrylsäure
• – Copolymere von Trimethylammoniumethylacrylamid mit Crotonsäure
• – Copolymere von Trimethylammoniumethylacrylamid mit 2-Methyl-crotonsäure
• – Copolymere von Trimethylammoniumethylmethacrylamid mit Acrylsäure
• – Copolymere von Trimethylammoniumethylmethacrylamid mit Methacrylsäure
• – Copolymere von Trimethylammoniumethylmethacrylamid mit Crotonsäure
• – Copolymere von Trimethylammoniumethylmethacrylamid mit 2-Methyl-crotonsäure
• – Copolymere von Trimethylammoniumpropylacrylamid mit Acrylsäure
• – Copolymere von Trimethylammoniumpropylacrylamid mit Methacrylsäure
• – Copolymere von Trimethylammoniumpropylacrylamid mit Crotonsäure
• – Copolymere von Trimethylammoniumpropylacrylamid mit 2-Methyl-crotonsäure
• – Copolymere von Trimethylammoniumpropylmethacrylamid mit Acrylsäure
• – Copolymere von Trimethylammoniumpropylmethacrylamid mit Methacrylsäure
• – Copolymere von Trimethylammoniumpropylmethacrylamid mit Crotonsäure
• – Copolymere von Trimethylammoniumpropylmethacrylamid mit 2-Methyl-crotonsäure
• – Copolymere von Trimethylammoniumethylacrylamid mit Acrylsäure
• – Copolymere von Trimethylammoniumethylacrylamid mit Methacrylsäure
• – Copolymere von Trimethylammoniumethylacrylamid mit Crotonsäure
• – Copolymere von Trimethylammoniumethylacrylamid mit 2-Methyl-crotonsäure
• – Copolymere von Trimethylammoniumethylacrylat mit Acrylsäure
• – Copolymere von Trimethylammoniumethylacrylat mit Methacrylsäure
• – Copolymere von Trimethylammoniumethylacrylat mit Crotonsäure
• – Copolymere von Trimethylammoniumethylacrylat mit 2-Methyl-crotonsäure
• – Copolymere von Trimethylammoniumethylmethacrylat mit Acrylsäure
• – Copolymere von Trimethylammoniumethylmethacrylat mit Methacrylsäure
• – Copolymere von Trimethylammoniumethylmethacrylat mit Crotonsäure
• – Copolymere von Trimethylammoniumethylmethacrylat mit 2-Methyl-crotonsäure
• – Copolymere von Trimethylammoniumethylacrylat mit Acrylsäure
• – Copolymere von Trimethylammoniumethylacrylat mit Methacrylsäure
• – Copolymere von Trimethylammoniumethylacrylat mit Crotonsäure
• – Copolymere von Trimethylammoniumethylacrylat mit 2-Methyl-crotonsäure
• – Copolymere von Ethyldimethylammoniumethylacrylamid mit Acrylsäure
• – Copolymere von Ethyldimethylammoniumethylacrylamid mit Methacrylsäure
• – Copolymere von Ethyldimethylammoniumethylacrylamid mit Crotonsäure
• – Copolymere von Ethyldimethylammoniumethylacrylamid mit 2-Methyl-crotonsäure
• – Copolymere von Ethyldimethylammoniumethylmethacrylamid mit Acrylsäure
• – Copolymere von Ethyldimethylammoniumethylmethacrylamid mit Methacrylsäure
• – Copolymere von Ethyldimethylammoniumethylmethacrylamid mit Crotonsäure
• – Copolymere von Ethyldimethylammoniumethylmethacrylamid mit 2-Methyl-crotonsäure
• – Copolymere von Ethyldimethylammoniumpropylacrylamid mit Acrylsäure
• – Copolymere von Ethyldimethylammoniumpropylacrylamid mit Methacrylsäure
• – Copolymere von Ethyldimethylammoniumpropylacrylamid mit Crotonsäure
• – Copolymere von Ethyldimethylammoniumpropylacrylamid mit 2-Methyl-crotonsäure
• – Copolymere von Ethyldimethylammoniumpropylmethacrylamid mit Acrylsäure
• – Copolymere von Ethyldimethylammoniumpropylmethacrylamid mit Methacrylsäure
• – Copolymere von Ethyldimethylammoniumpropylmethacrylamid mit Crotonsäure
• – Copolymere von Ethyldimethylammoniumpropylmethacrylamid mit 2-Methyl-crotonsäure
• – Copolymere von Ethyldimethylammoniumethylacrylamid mit Acrylsäure
• – Copolymere von Ethyldimethylammoniumethylacrylamid mit Methacrylsäure
• – Copolymere von Ethyldimethylammoniumethylacrylamid mit Crotonsäure
• – Copolymere von Ethyldimethylammoniumethylacrylamid mit 2-Methyl-crotonsäure
• – Copolymere von Ethyldimethylammoniumethylacrylat mit Acrylsäure
• – Copolymere von Ethyldimethylammoniumethylacrylat mit Methacrylsäure
• – Copolymere von Ethyldimethylammoniumethylacrylat mit Crotonsäure
• – Copolymere von Ethyldimethylammoniumethylacrylat mit 2-Methyl-crotonsäure
• – Copolymere von Ethyldimethylammoniumethylmethacrylat mit Acrylsäure
• – Copolymere von Ethyldimethylammoniumethylmethacrylat mit Methacrylsäure
• – Copolymere von Ethyldimethylammoniumethylmethacrylat mit Crotonsäure
• – Copolymere von Ethyldimethylammoniumethylmethacrylat mit 2-Methyl-crotonsäure
• – Copolymere von Ethyldimethylammoniumethylacrylat mit Acrylsäure
• – Copolymere von Ethyldimethylammoniumethylacrylat mit Methacrylsäure
• – Copolymere von Ethyldimethylammoniumethylacrylat mit Crotonsäure
• – Copolymere von Ethyldimethylammoniumethylacrylat mit 2-Methyl-crotonsäure

Particularly preferred amphoteric polymers according to the invention are:

• - Copolymers of trimethylammoniumethylacrylamide with acrylic acid
• - Copolymers of trimethylammoniumethylacrylamide with methacrylic acid
• - Copolymers of trimethylammoniumethylacrylamide with crotonic acid
• - Copolymers of trimethylammoniumethylacrylamide with 2-methyl-crotonic acid
• - Copolymers of trimethylammoniumethylmethacrylamide with acrylic acid
• - Copolymers of trimethylammoniumethylmethacrylamide with methacrylic acid
• - Copolymers of trimethylammoniumethylmethacrylamide with crotonic acid
• - Copolymers of trimethylammoniumethylmethacrylamide with 2-methyl-crotonic acid
• - Copolymers of trimethylammoniumpropylacrylamide with acrylic acid
• - Copolymers of trimethylammoniumpropylacrylamide with methacrylic acid
• - Copolymers of trimethylammoniumpropylacrylamide with crotonic acid
• - Copolymers of trimethylammoniumpropylacrylamide with 2-methyl-crotonic acid
• - Copolymers of trimethylammoniumpropylmethacrylamide with acrylic acid
• - Copolymers of trimethylammoniumpropylmethacrylamide with methacrylic acid
• - Copolymers of trimethylammoniumpropylmethacrylamide with crotonic acid
• - Copolymers of trimethylammonium propylmethacrylamide with 2-methyl-crotonic acid
• - Copolymers of trimethylammoniumethylacrylamide with acrylic acid
• - Copolymers of trimethylammoniumethylacrylamide with methacrylic acid
• - Copolymers of trimethylammoniumethylacrylamide with crotonic acid
• - Copolymers of trimethylammoniumethylacrylamide with 2-methyl-crotonic acid
• - Copolymers of trimethylammonium ethyl acrylate with acrylic acid
• - Copolymers of trimethylammonium ethyl acrylate with methacrylic acid
• - Copolymers of trimethylammonium ethyl acrylate with crotonic acid
• - Copolymers of trimethylammonium ethyl acrylate with 2-methyl-crotonic acid
• - Copolymers of trimethylammonium ethyl methacrylate with acrylic acid
• - Copolymers of trimethylammoniumethyl methacrylate with methacrylic acid
• - Copolymers of trimethylammonium ethyl methacrylate with crotonic acid
• - Copolymers of trimethylammonium ethyl methacrylate with 2-methyl-crotonic acid
• - Copolymers of trimethylammonium ethyl acrylate with acrylic acid
• - Copolymers of trimethylammonium ethyl acrylate with methacrylic acid
• - Copolymers of trimethylammonium ethyl acrylate with crotonic acid
• - Copolymers of trimethylammonium ethyl acrylate with 2-methyl-crotonic acid
• - Copolymers of Ethyldimethylammoniumethylacrylamid with acrylic acid
• - Copolymers of ethyldimethylammoniumethylacrylamide with methacrylic acid
• - Copolymers of ethyldimethylammoniumethylacrylamide with crotonic acid
• - Copolymers of Ethyldimethylammoniumethylacrylamid with 2-methyl crotonic acid
• - Copolymers of Ethyldimethylammoniumethylmethacrylamid with acrylic acid
• - Copolymers of ethyldimethylammoniumethylmethacrylamide with methacrylic acid
• - Copolymers of ethyldimethylammoniumethylmethacrylamide with crotonic acid
• - Copolymers of Ethyldimethylammoniumethylmethacrylamid with 2-methyl-crotonic acid
• - Copolymers of ethyldimethylammoniumpropylacrylamide with acrylic acid
• - Copolymers of ethyldimethylammoniumpropylacrylamide with methacrylic acid
• Copolymers of ethyldimethylammoniumpropylacrylamide with crotonic acid
• - Copolymers of ethyldimethylammoniumpropylacrylamide with 2-methyl-crotonic acid
• - Copolymers of ethyldimethylammoniumpropylmethacrylamide with acrylic acid
• - Copolymers of ethyldimethylammoniumpropylmethacrylamide with methacrylic acid
• Copolymers of ethyldimethylammoniumpropylmethacrylamide with crotonic acid
• - Copolymers of ethyldimethylammoniumpropylmethacrylamide with 2-methyl-crotonic acid
• - Copolymers of Ethyldimethylammoniumethylacrylamid with acrylic acid
• - Copolymers of ethyldimethylammoniumethylacrylamide with methacrylic acid
• - Copolymers of ethyldimethylammoniumethylacrylamide with crotonic acid
• - Copolymers of Ethyldimethylammoniumethylacrylamid with 2-methyl crotonic acid
• - Copolymers of ethyldimethylammonium ethyl acrylate with acrylic acid
• - Copolymers of ethyldimethylammonium ethyl acrylate with methacrylic acid
• - Copolymers of ethyldimethylammonium ethyl acrylate with crotonic acid
• - Copolymers of ethyldimethylammonium ethyl acrylate with 2-methyl-crotonic acid
• - Copolymers of ethyldimethylammoniumethyl methacrylate with acrylic acid
• - Copolymers of ethyldimethylammonium ethyl methacrylate with methacrylic acid
• - Copolymers of ethyldimethylammonium ethyl methacrylate with crotonic acid
• - Copolymers of ethyldimethylammoniumethyl methacrylate with 2-methyl-crotonic acid
• - Copolymers of ethyldimethylammonium ethyl acrylate with acrylic acid
• - Copolymers of ethyldimethylammonium ethyl acrylate with methacrylic acid
• - Copolymers of ethyldimethylammonium ethyl acrylate with crotonic acid
• - Copolymers of ethyldimethylammonium ethyl acrylate with 2-methyl-crotonic acid

When Furthermore, it has proved advantageous, in addition to the polymer (s) from the group of cationic and / or amphoteric polymers further polymers (G) in the inventive compositions are included. In a preferred embodiment, the agents according to the invention therefore additional polymers are added, both anionic and also non-ionic polymers have been found to be effective.

The anionic polymers (G2) are anionic polymers which carboxylate and / or sulfonate groups. Examples of anionic monomers from which such polymers may consist are acrylic acid, methacrylic acid, crotonic acid, maleic anhydride and 2-acrylamido-2-methylpropanesulfonic acid. The acidic groups may be wholly or partly present as sodium, potassium, ammonium, mono- or triethanolammonium salt. Preferred monomers are 2-acrylamido-2-methylpropanesulfonic acid and acrylic acid.

When anionic polymers have proven to be particularly effective containing as sole or co-monomer 2-acrylamido-2-methylpropanesulfonic acid, wherein the sulfonic acid group wholly or partly as sodium, potassium, ammonium, mono- or Triethanolammonium salt may be present.

More preferably, the homopolymer of 2-acrylamido-2-methyl propane sulfonic acid, which is available for example under the name Rheothik ^® 11-80 is commercially.

Within this embodiment For example, it may be preferable to use copolymers of at least one anionic Use monomer and at least one nonionic monomer. In terms of The anionic monomers are based on the substances listed above directed. Preferred nonionic monomers are acrylamide, methacrylamide, acrylate, methacrylates, Vinyl pyrrolidone, vinyl ethers and vinyl esters.

Preferred anionic copolymers are acrylic acid-acrylamide copolymers and in particular polyacrylamide copolymers with sulfonic acid-containing monomers. A particularly preferred anionic copolymer consists of 70 to 55 mol% of acrylamide and 30 to 45 mol% of 2-acrylamido-2-methylpropanesulfonic acid, wherein the sulfonic acid group is wholly or partly in the form of sodium, potassium, ammonium, mono- or triethanolammonium Salt is present. This copolymer may also be crosslinked, with crosslinking agents preferably polyolefinically unsaturated compounds such as tetraallyloxyethane, allylsucrose, allylpentaerythritol and methylene-bisacrylamide are used. Such a polymer is contained in the commercial product Sepigel ^® 305 from SEPPIC. The use of this compound, which in addition to the polymer component contains a hydrocarbon mixture (C ₁₃ -C ₁₄ isoparaffin) and a nonionic emulsifier (laureth-7), has proved to be particularly advantageous within the scope of the teaching according to the invention.

Also sold under the name Simulgel ^® 600 as a compound with isohexadecane and polysorbate-80 Natriumacryloyldimethyltaurat copolymers have proved to be particularly effective according to the invention.

Likewise preferred anionic homopolymers are uncrosslinked and crosslinked polyacrylic acids. Allyl ethers of pentaerythritol, sucrose and propylene may be preferred crosslinking agents. Such compounds are for example available under the trademark Carbopol ^® commercially.

Copolymers of maleic anhydride and methyl vinyl ether, especially those with crosslinks, are also color-retaining polymers. A with 1,9-decadiene crosslinked maleic acid-methyl vinyl ether copolymer is commercially available under the name Stabileze® ^® QM.

The agents according to the invention can in a further embodiment non-ionic polymers (G4).

• – Vinylpyrrolidon/Vinylester-Copolymere, wie sie beispielsweise unter dem Warenzeichen Luviskol^® (BASF) vertrieben werden. Luviskol^® VA 64 und Luviskol^® VA 73, jeweils Vinylpyrrolidon/Vinylacetat-Copolymere, sind ebenfalls bevorzugte nichtionische Polymere.
• – Celluloseether, wie Hydroxypropylcellulose, Hydroxyethylcellulose und Methylhydroxypropylcellulose, wie sie beispielsweise unter den Warenzeichen Culminal^® und Benecel^® (AQUALON) und Natrosol^®-Typen (Hercules) vertrieben werden.
• – Stärke und deren Derivate, insbesondere Stärkeether, beispielsweise Structure^® XL (National Starch), eine multifunktionelle, salztolerante Stärke;
• – Schellack
• – Polyvinylpyrrolidone, wie sie beispielsweise unter der Bezeichnung Luviskol^® (BASF) vertrieben werden.
• – Siloxane. Diese Siloxane können sowohl wasserlöslich als auch wasserunlöslich sein. Geeignet sind sowohl flüchtige als auch nichtflüchtige Siloxane, wobei als nichtflüchtige Siloxane solche Verbindungen verstanden werden, deren Siedepunkt bei Normaldruck oberhalb von 200 °C liegt. Bevorzugte Siloxane sind Polydialkylsiloxane, wie beispielsweise Polydimethylsiloxan, Polyalkylarylsiloxane, wie beispielsweise Polyphenylmethylsiloxan, ethoxylierte Polydialkylsiloxane sowie Polydialkylsiloxane, die Amin- und/oder Hydroxy-Gruppen enthalten.
• – Glycosidisch substituierte Silicone.

Suitable nonionic polymers are, for example:

• - Vinylpyrrolidone / vinyl ester copolymers, such as those sold under the trademark Luviskol ^® (BASF). Luviskol ^® VA 64 and Luviskol ^® VA 73, each vinylpyrrolidone / vinyl acetate copolymers, are also preferred nonionic polymers.
• - cellulose ethers such as hydroxypropyl cellulose, hydroxyethyl cellulose and methylhydroxypropyl cellulose, as for example under the trademark Culminal® ^® and Benecel ^® (AQUALON) and Natrosol ^® grades (Hercules) are distributed.
• - starch and its derivatives, in particular starch, such as Structure XL ^® (National Starch), a multifunctional, salt-tolerant starch;
• - shellac
• - polyvinylpyrrolidones, as for example under the name Luviskol ^® (BASF).
• - siloxanes. These siloxanes can be both water-soluble and water-insoluble. Both volatile and nonvolatile siloxanes are suitable, nonvolatile siloxanes being understood as meaning those compounds whose boiling point is above 200 ° C. under normal pressure. Preferred siloxanes are polydialkylsiloxanes, such as, for example, polydimethylsiloxane, polyalkylarylsiloxanes, such as, for example, polyphenylmethylsiloxane, ethoxylated polydialkylsiloxanes and polydialkylsiloxanes which contain amine and / or hy contain droxy groups.
• - Glycosidically substituted silicones.

It It is also possible according to the invention that the preparations several, in particular two different polymers of the same charge and / or in each case an ionic and an amphoteric and / or not contain ionic polymer.

The further polymers (G) are preferred in amounts in the agents according to the invention from 0.05 to 10 wt .-%, based on the total agent. Amounts of 0.1 to 5, in particular from 0.1 to 3 wt .-%, are particularly prefers.

The agents according to the invention can additionally contain at least one emulsifier or a surfactant, wherein surface-active Substances depending on the field of application as surfactants or as emulsifiers and anionic, cationic, zwitterionic, ampholytic and nonionic surfactants and emulsifiers are selected.

• – lineare und verzweigte Fettsäuren mit 8 bis 30 C-Atomen (Seifen),
• – Ethercarbonsäuren der Formel R-O-(CH₂-CH₂O)_x-CH₂-COOH, in der R eine lineare Alkylgruppe mit 8 bis 30 C-Atomen und x = 0 oder 1 bis 16 ist,
• – Acylsarcoside mit 8 bis 24 C-Atomen in der Acylgruppe,
• – Acyltauride mit 8 bis 24 C-Atomen in der Acylgruppe,
• – Acylisethionate mit 8 bis 24 C-Atomen in der Acylgruppe,
• – lineare Alkansulfonate mit 8 bis 24 C-Atomen,
• – lineare Alpha-Olefinsulfonate mit 8 bis 24 C-Atomen,
• – Alpha-Sulfofettsäuremethylester von Fettsäuren mit 8 bis 30 C-Atomen,
• – Acylglutamate der Formel (I),
  
  in der R¹CO für einen linearen oder verzweigten Acylrest mit 6 bis 22 Kohlenstoffatomen und 0, 1, 2 oder 3 Doppelbindungen und X für Wasserstoff, ein Alkali- und/oder Erdalkalimetall, Ammonium, Alkylammonium, Alkanolammonium oder Glucammonium steht, beispielsweise Acylglutamate, die sich von Fettsäuren mit 6 bis 22, vorzugsweise 12 bis 18 Kohlenstoffatomen ableiten, wie beispielsweise C_12/14- bzw. C_12/18-Kokosfettsäure, Laurinsäure, Myristinsäure, Palmitinsäure und/oder Stearinsäure, insbesondere Natrium-N-cocoyl- und Natrium-N-stearoyl-L-glutamat,
• – Ester einer hydroxysubstituierten Di- oder Tricarbonsäure der allgemeinen Formel (II),
  
  in der X=H oder eine -CH₂COOR-Gruppe ist, Y=H oder -OH ist unter der Bedingung, dass Y=H ist, wenn X=-CH₂COOR ist, R, R¹ und R² unabhängig voneinander ein Wasserstoffatom, ein Alkali- oder Erdalkalimetallkation, eine Ammoniumgruppe, das Kation einer ammonium-organischen Base oder einen Rest Z bedeuten, der von einer polyhydroxylierten organischen Verbindung stammt, die aus der Gruppe der veretherten (C₆-C₁₈)-Alkylpolysaccharide mit 1 bis 6 monomeren Saccharideinheiten und/oder der veretherten aliphatischen (C₆-C₁₆)-Hydroxyalkylpolyole mit 2 bis 16 Hydroxylresten ausgewählt sind, unter der Maßgabe, dass wenigstens eine der Gruppen R, R¹ oder R² ein Rest Z ist,
• – Ester der Sulfobernsteinsäure oder der Sulfosuccinate der allgemeinen Formel (III),
  
  in der M^(n+/n) für n = 1 ein Wasserstoffatom, ein Alkalimetallkation, eine Ammoniumgruppe oder das Kation einer ammonium-organischen Base und für n = 2 ein Erdalkalimetallkation darstellt und R¹ und R² unabhängig voneinander ein Wasserstoffatom, ein Alkali- oder Erdalkalimetallkation, eine Ammoniumgruppe, das Kation einer ammonium-organischen Base oder einen Rest Z bedeuten, der von einer polyhydroxylierten organischen Verbindung stammt, die aus der Gruppe der veretherten (C₆-C₁₈)-Alkylpolysaccharide mit 1 bis 6 monomeren Saccharideinheiten und/oder der veretherten aliphatischen (C₆-C₁₆)-Hydroxyalkylpolyole mit 2 bis 16 Hydroxylresten ausgewählt ist, unter der Maßgabe, dass wenigstens eine der Gruppen R¹ oder R² ein Rest Z ist,
• – Sulfobernsteinsäuremono- und -dialkylester mit 8 bis 24 C-Atomen in der Alkylgruppe und Sulfobernsteinsäuremonoalkylpolyoxyethylester mit 8 bis 24 C-Atomen in der Alkylgruppe und 1 bis 6 Oxyethylgruppen,
• – Alkylsulfate und Alkylpolyglycolethersulfate der Formel R-(O-CH₂-CH₂)_x-OSO₃H, in der R eine bevorzugt lineare Alkylgruppe mit 8 bis 30 C-Atomen und x = 0 oder 1-12 ist,
• – gemischte oberflächenaktive Hydroxysulfonate gemäß DE-A-37 25 030 ,
• – Ester der Weinsäure und Zitronensäure mit Alkoholen, die Anlagerungsprodukte von etwa 2-15 Molekülen Ethylenoxid und/oder Propylenoxid an C_8-22-Fettalkohole darstellen,
• – Alkyl- und/oder Alkenyletherphosphate,
• – sulfatierte Fettsäurealkylenglycolester,
• – Monoglyceridsulfate und Monoglyceridethersulfate.

Suitable anionic surfactants and emulsifiers for the compositions according to the invention are all anionic surfactants suitable for use on the human body. These are characterized by a water-solubilizing, anionic group such as. As a carboxylate, sulfate, sulfonate or phosphate group and a lipophilic alkyl group having about 8 to 30 carbon atoms. In addition, glycol or polyglycol ether groups, ester, ether and amide groups and hydroxyl groups may be present in the molecule. Examples of suitable anionic surfactants and emulsifiers are, in each case in the form of the sodium, potassium and ammonium as well as the mono-, di- and trialkanolammonium salts having 2 to 4 C atoms in the alkanol group,

• - linear and branched fatty acids with 8 to 30 carbon atoms (soaps),
• Ether carboxylic acids of the formula RO- (CH ₂ -CH ₂ O) _x -CH ₂ -COOH, in which R is a linear alkyl group having 8 to 30 C atoms and x = 0 or 1 to 16,
• Acylsarcosides having 8 to 24 C atoms in the acyl group,
• Acyltaurides having 8 to 24 carbon atoms in the acyl group,
• Acyl isethionates having 8 to 24 C atoms in the acyl group,
• - linear alkanesulfonates having 8 to 24 carbon atoms,
• - linear alpha-olefin sulfonates having 8 to 24 carbon atoms,
• Alpha-sulfofatty acid methyl esters of fatty acids having 8 to 30 C atoms,
• Acylglutamates of the formula (I),
  
  in which R ¹ CO is a linear or branched acyl radical having 6 to 22 carbon atoms and 0, 1, 2 or 3 double bonds and X is hydrogen, an alkali and / or alkaline earth metal, ammonium, alkylammonium, alkanolammonium or glucammonium, for example acylglutamates, which are derived from fatty acids having 6 to 22, preferably 12 to 18 carbon atoms, such as, for example, C _12/14 or C _12/18 coconut fatty acid, lauric acid, myristic acid, palmitic acid and / or stearic acid, in particular sodium N-cocoyl and sodium N-stearoyl-L-glutamate,
• Esters of a hydroxy-substituted di- or tricarboxylic acid of the general formula (II),
  
  wherein X is H or a -CH ₂ COOR group, Y is H or -OH is under the condition that Y is H when X is -CH ₂ COOR, R, R ¹ and R ^{2 are} independently a hydrogen atom, an alkali or alkaline earth metal cation, an ammonium group, the cation of an ammonium organic base or a radical Z derived from a polyhydroxylated organic compound selected from the group of etherified (C ₆ -C ₁₈ ) alkyl polysaccharides with 1 to 6 monomeric saccharide units and / or the etherified aliphatic (C ₆ -C ₁₆ ) -hydroxyalkylpolyols having 2 to 16 hydroxyl radicals, with the proviso that in that at least one of the groups R, R ¹ or R ^{2 is} a radical Z,
• Esters of sulfosuccinic acid or sulfosuccinates of general formula (III),
  
  in which M ^{(n + / n)} for n = 1 represents a hydrogen atom, an alkali metal cation, an ammonium group or the cation of an ammonium organic base and for n = 2 an alkaline earth metal cation and R ¹ and R ² independently of one another represent a hydrogen atom, an alkali metal cation or alkaline earth metal cation, an ammonium group, the cation of an ammonium organic base or a radical Z derived from a polyhydroxylated organic compound selected from the group consisting of etherified (C ₆ -C ₁₈ ) -alkyl polysaccharides having 1 to 6 monomeric saccharide units and / or the etherified aliphatic (C ₆ -C ₁₆ ) -hydroxyalkylpolyols having 2 to 16 hydroxyl radicals, with the proviso that at least one of the groups R ¹ or R ^{2 is} a radical Z,
• Sulfosuccinic acid mono- and dialkyl esters having 8 to 24 C atoms in the alkyl group and sulfosuccinic monoalkylpolyoxyethyl esters having 8 to 24 C atoms in the alkyl group and 1 to 6 oxyethyl groups,
• Alkyl sulfates and alkyl polyglycol ether sulfates of the formula R- (O-CH ₂ -CH ₂ ) _x -OSO ₃ H, in which R is a preferably linear alkyl group having 8 to 30 C atoms and x = 0 or 1-12,
• Mixed hydroxysulfonates according to DE-A-37 25 030 .
• Esters of tartaric acid and citric acid with alcohols which are adducts of about 2-15 molecules of ethylene oxide and / or propylene oxide with C _8-22 fatty alcohols,
• Alkyl and / or alkenyl ether phosphates,
• - sulfated fatty acid alkylene glycol esters,
• Monoglyceride sulfates and monoglyceride ether sulfates.

Preferred anionic surfactants and emulsifiers are acylglutamates, acyl isethionates, acyl sarcosinates and acyl taurates, each with a linear or branched acyl radical having 6 to 22 carbon atoms and 0, 1, 2 or 3 double bonds, which in particularly preferred embodiments of an octanoyl, decanoyl, lauroyl , Myristoyl, palmitoyl and stearoyl radical, esters of tartaric acid, citric acid or succinic acid or of the salts of these acids with alkylated glucose, in particular the products with the INCI name Disodium Coco-Glucoside Citrate, Sodium Coco-Glucoside Tartrate and Disodium Coco-glucosides sulfosuccinates, alkyl polyglycol ether sulfates and ether carboxylic acids having 8 to 18 carbon atoms in the alkyl group and up to 12 ethoxy groups in the molecule, sulfosuccinic acid mono- and dialkyl esters having 8 to 18 carbon atoms in the alkyl group and sulfosuccinic monoalkylpolyoxyethyl ester having 8 to 18 carbon atoms in the alkyl group and 1 to 6 ethoxy groups. Zwitterionic surfactants and emulsifiers are those surface-active compounds which carry in the molecule at least one quaternary ammonium group and at least one - COO ^(-) or -SO ₃ ^(-) group. Particularly suitable zwitterionic surfactants and emulsifiers are the so-called betaines such as N-alkyl-N, N-dimethylammonium glycinates, for example cocoalkyldimethylammonium glycinate, N-acylaminopropyl-N, N-dimethylammonium glycinates, for example cocoacylaminopropyldimethylammonium glycinate, and 2-alkyl-3-carboxymethyl 3-hydroxyethylimidazolines each having 8 to 18 carbon atoms in the alkyl or acyl group and cocoacylaminoethylhydroxyethylcarboxymethylglycinate. A preferred zwitterionic surfactant is the fatty acid amide derivative known by the INCI name Cocamidopropyl Betaine.

Ampholytic surfactants and emulsifiers are understood to mean those surface-active compounds which, apart from a C ₈ -C ₂₄ -alkyl or -acyl group, contain at least one free amino group and at least one -COOH or -SO ₃ H group and are capable of forming internal salts , Examples of suitable ampholytic surfactants are N-alkylglycines, N-alkylaminopropionic acids, N-alkylaminobutyric acids, N-alkyliminodipropionic acids, N-hydroxyethyl-N-alkylamidopropylglycines, N-alkyltaurines, N-alkylsarcosines, 2-alkylaminopropionic acids and alkylaminoacetic acids each having about 8 to 24 C Atoms in the alkyl group. Particularly preferred ampholytic surfactants are N-cocoalkylaminopropionate, cocoacylaminoethylaminopropionate and C ₁₂ -C ₁₈ acylsarcosine.

• – Anlagerungsprodukte von 2 bis 50 Mol Ethylenoxid und/oder 0 bis 5 Mol Propylenoxid an lineare und verzweigte Fettalkohole mit 8 bis 30 C-Atomen, an Fettsäuren mit 8 bis 30 C-Atomen und an Alkylphenole mit 8 bis 15 C-Atomen in der Alkylgruppe,
• – C₁₂-C₃₀-Fettsäuremono- und -diester von Anlagerungsprodukten von 1 bis 30 Mol Ethylenoxid an Polyole mit 3 bis 6 Kohlenstoffatomen, insbesondere an Glycerin,
• – Anlagerungsprodukte von 5 bis 60 Mol Ethylenoxid an Rizinusöl und gehärtetes Rizinusöl,
• – Polyolfettsäure(partial)ester, wie Hydagen^® HSP (Cognis) oder Sovermol^®-Typen (Cognis), insbesondere von gesättigten C_8-30-Fettsäuren,
• – alkoxylierte Triglyceride,
• – alkoxylierte Fettsäurealkylester,
• – Aminoxide,
• – Fettsäurealkanolamide, Fettsäure-N-alkylglucamide und Fettamine sowie deren Ethylenoxid- oder Polyglycerin-Anlagerungsprodukte,
• – Sorbitanfettsäureester und Anlagerungsprodukte von Ethylenoxid an Sorbitanfettsäureester wie beispielsweise die Polysorbate,
• – Zuckerfettsäureester und Methylglucosid-Fettsäureester sowie deren Ethylenoxid- oder Polyglycerin-Anlagerungsprodukte,
• – Alkylpolyglycoside entsprechend der allgemeinen Formel RO-(Z)_x wobei R für Alkyl, Z für Zucker sowie x für die Anzahl der Zuckereinheiten steht. Besonders bevorzugt sind solche Alkylpolyglycoside, bei denen R
• – im wesentlichen aus C₈- und C₁₀-Alkylgruppen,
• – im wesentlichen aus C₁₂- und C₁₄-Alkylgruppen,
• – im wesentlichen aus C₈- bis C₁₆-Alkylgruppen oder
• – im wesentlichen aus C₁₂- bis C₁₆-Alkylgruppen oder
• – im wesentlichen aus C₁₆ bis C₁₈-Alkylgruppen

besteht.Nonionic surfactants and emulsifiers contain as hydrophilic group z. A polyol group, a polyalkylene glycol ether group or a combination of polyol and polyglycol ether groups. Such compounds are, for example

• - Addition products of 2 to 50 moles of ethylene oxide and / or 0 to 5 moles of propylene oxide to linear and branched fatty alcohols having 8 to 30 carbon atoms, to fatty acids having 8 to 30 carbon atoms and to alkylphenols having 8 to 15 carbon atoms in the alkyl group,
• C ₁₂ -C ₃₀ -fatty acid mono- and diesters of addition products of from 1 to 30 mol of ethylene oxide onto polyols having from 3 to 6 carbon atoms, in particular to glycerol,
• Adducts of 5 to 60 moles of ethylene oxide with castor oil and hydrogenated castor oil,
• - polyol fatty (partial) ester as Hydagen ^® HSP (Cognis) or Sovermol ^® grades (Cognis), especially of saturated C _8-30 fatty acids,
• - alkoxylated triglycerides,
• - alkoxylated fatty acid alkyl esters,
• - amine oxides,
• Fatty acid alkanolamides, fatty acid N-alkylglucamides and fatty amines and their ethylene oxide or polyglycerol addition products,
• Sorbitan fatty acid esters and adducts of ethylene oxide with sorbitan fatty acid esters such as the polysorbates,
• Sugar fatty acid esters and methyl glucoside fatty acid esters and their ethylene oxide or polyglycerol addition products,
• - Alkylpolyglycoside according to the general formula RO- (Z) _x wherein R is alkyl, Z is sugar and x is the number of sugar units. Particular preference is given to those alkylpolyglycosides in which R
• Consisting essentially of C ₈ and C ₁₀ -alkyl groups,
• Essentially of C ₁₂ and C ₁₄ alkyl groups,
• - Essentially from C ₈ - to C ₁₆ alkyl groups or
• - Essentially from C ₁₂ - to C ₁₆ alkyl groups or
• - Substituted from C ₁₆ to C ₁₈ alkyl groups

consists.

When Sugar component Z can any mono- or oligosaccharides are used. Usually Sugar with 5 or 6 carbon atoms and the corresponding oligosaccharides used. Such sugars are, for example, glucose, fructose, Galactose, arabinose, ribose, xylose, lyxose, allose, altrose, mannose, Gulose, idose, talose and sucrose. Preferred sugar building blocks are Glucose, fructose, galactose, arabinose and sucrose; Glucose is particularly preferred.

• – Gemische aus Alkyl-(oligo)-glucosiden und Fettalkoholen, z. B. Montanov^®68,
• – Sterine, z. B. Ergosterin, Stigmasterin, Sitosterin und Mykosterine,
• – Phospholipide, z. B. Lecithine bzw. Phosphatidylcholine,
• – Polyglycerine und Polyglycerinderivate wie beispielsweise Polyglycerinpoly-12-hydroxystearat (Dehymuls^® PGPH) oder Triglycerindiisostearat (Lameform^® TGI),
• – alkoxylierte Polydialkylsiloxane (INCI-Bezeichnung: Dimethicone Copolyol).

The alkylpolyglycosides which can be used according to the invention contain on average from 1.1 to 5 sugar units. Alkyl polyglycosides having x values of 1.1 to 2.0 are preferred. Very particular preference is given to alkyl glycosides in which x is 1.1 to 1.8.

• - Mixtures of alkyl (oligo) glucosides and fatty alcohols, eg. B. Montanov ^® 68,
• - sterols, e.g. Ergosterol, stigmasterol, sitosterol and mycosterols,
• - Phospholipids, z. B. lecithins or phosphatidylcholines,
• - polyglycerols and polyglycerol derivatives such as polyglycerol poly-12-hydroxystearate (Dehymuls ^® PGPH) or Triglycerindiisostearat (Lameform ^® TGI),
• - alkoxylated polydialkylsiloxanes (INCI name: Dimethicone Copolyol).

When preferred nonionic surfactant Substances have the alkyl polyglycosides, optionally in Mixture with fatty alcohols, alkoxylated polydialkylsiloxanes, alkylene oxide addition products saturated linear fatty alcohols and fatty acids with in each case 2 to 30 moles of ethylene oxide per mole of fatty alcohol or fatty acid.

Usable according to the invention are also cationic surfactants of the quaternary ammonium type, the esterquats and the amidoamines. Preferred quaternary ammonium compounds are ammonium halides, especially chlorides and bromides, such as Alkyltrimethylammonium chlorides, dialkyldimethylammonium chlorides and trialkylmethylammonium chlorides. The long alkyl chains of this Surfactants preferably have 10 to 18 carbon atoms, such as Z. In cetyltrimethylammonium chloride, stearyltrimethylammonium chloride, Distearyldimethylammonium chloride, lauryldimethylammonium chloride, Lauryldimethylbenzylammonium chloride and tricetylmethylammonium chloride. Other preferred cationic surfactants are those under the INCI names Quaternium-27 and quaternium-83 known imidazolium compounds.

Very particularly preferred are agents according to the invention which additionally contain fatty alcohol (s) and / or fatty alcohol alkoxylate (s), preferably C _12-22 fatty alcohol (s) and / or C _12-22 fatty alcohol ethoxylate (s) with 10 to 30 EO units , Particularly preferably C _16-18 fatty alcohol (s) and / or C _16-18 fatty alcohol ethoxylate (s) having 12 to 20 EO units, preferably in amounts of 5 to 20 wt .-%, preferably from 7.5 to 17.5 wt .-% and in particular from 10 to 15 wt .-%, each based on the weight of the composition.

In summary, agents according to the invention which additionally comprise surfactant (s), preferably anionic surfactant (s), particularly preferably fatty alcohol ether sulfates of the formula H ₃ C- (CH ₂ ) _n - (OCH ₂ CH ₂ ) _k -OSO ₃ ^- M ⁺ in which n represents values of from 5 to 21, preferably from 7 to 19, more preferably from 9 to 17 and in particular from 11 to 13 and k for values of 1, 2, 3, 4 or 4, preferably for 2, and M is a cation from the group Na ⁺ , K ⁺ NH ₄ ⁺ , ½ Mg ²⁺ , ½ Zn ²⁺ , preferably Na ⁺ , preferred agents being the surfactant (s) in amounts of 2 to 20 Wt .-%, preferably from 5 to 15 wt .-% and in particular from 7.5 to 12 wt .-%, each based on the total agent included.

Preferred agents according to the invention are characterized in that they additionally contain amphoteric surfactant (s), preferably from the groups of
N-alkyl,
N-alkyl propionic acids,
N-alkyl aminobutyric acids,
N-alkyliminodipropionic,
N-hydroxyethyl-N-alkylamido,
N-alkyltaurines
N-alkylsarcosines,
2-Alkylaminopropionsäuren each having about 8 to 24 carbon atoms in the alkyl group,
Alkylaminoacetic acids each having about 8 to 24 carbon atoms in the alkyl group,
N-cocoalkyl,
cocoacylaminoethylaminopropionate
C ₁₂ -C ₁₈ acyl sarcosine,
N-alkyl-N, N-dimethylammonium glycinates, for example cocoalkyldimethylammonium glycinate,
N-acyl-aminopropyl-N, N-dimethylammonium glycinates, for example cocoacylaminopropyl-dimethylammonium glycinate,
2-Alkyl-3-carboxymethyl-3-hydroxyethyl-imidazolines each having 8 to 18 carbon atoms in the alkyl or acyl group
Kokosacylaminoethylhydroxyethylcarboxymethylglycinat
the compounds known under the INCI name cocamidopropyl betaine,
the compounds known under the INCI name Disodium Cocoamphodiacetate,
preferred agents containing the amphoteric surfactant (s) in amounts of 1 to 15 wt .-%, preferably from 2.5 to 12 wt .-% and in particular from 5 to 10 wt .-%, in each case based on the total agent included.

As already mentioned, it may be beneficial to use lower levels of surfactant Use substances to the care performance of the compositions of the invention even further increase. In particular, the reduction of the content of anionic surfactants can be beneficial. Here, agents according to the invention are preferred, the less as 10% by weight, preferably less than 8% by weight, more preferably less than 4% by weight, more preferably less than 2% by weight, and in particular contain less than 1 wt .-% of anionic surfactants. Also preferred are agents which are completely free of anionic Surfactants. Also preferred is a reduction or a waiver to nonionic surfactants, wherein agents of this embodiment preferably less than 10% by weight, preferably less than 8% by weight, more preferably less than 4% by weight, more preferably less as 2% by weight and in particular less than 1% by weight of nonionic Containing surfactants.

In further preferred means the total surfactant content is less than 10% by weight, preferably less than 8% by weight, more preferably less than 4% by weight, more preferably less than 2 wt .-% and in particular less than 1 wt .-%, wherein preferred agents are formulated surfactant-free.

Another preferred group of ingredients of the compositions of the invention are vitamins, provitamins or vitamin precursors. These are described below: The group of substances called vitamin A includes retinol (vitamin A ₁ ) and 3,4-didehydroretinol (vitamin A ₂ ). The β-carotene is the provitamin of retinol. As vitamin A component according to the invention, for example, vitamin A acid and its esters, vitamin A aldehyde and vitamin A alcohol and its esters such as the palmitate and the acetate into consideration. The agents according to the invention preferably contain the vitamin A component in amounts of 0.05-1% by weight, based on the total preparation.

• – Vitamin B₁ (Thiamin)
• – Vitamin B₂ (Riboflavin)
• – Vitamin B₃. Unter dieser Bezeichnung werden häufig die Verbindungen Nicotinsäure und Nicotinsäureamid (Niacinamid) geführt. Erfindungsgemäß bevorzugt ist das Nicotinsäureamid, das in den erfindungsgemäß verwendetenen Mitteln bevorzugt in Mengen von 0,05 bis 1 Gew.-%, bezogen auf das gesamte Mittel, enthalten ist.
• – Vitamin B₅ (Pantothensäure, Panthenol und Pantolacton). Im Rahmen dieser Gruppe wird bevorzugt das Panthenol und/oder Pantolacton eingesetzt. Erfindungsgemäß einsetzbare Derivate des Panthenols sind insbesondere die Ester und Ether des Panthenols sowie kationisch derivatisierte Panthenole. Einzelne Vertreter sind beispielsweise das Panthenoltriacetat, der Panthenolmonoethylether und dessen Monoacetat sowie die in der WO 92/13829 offenbarten kationischen Panthenolderivate. Die genannten Verbindungen des Vitamin B₅-Typs sind in den erfindungsgemäßen Mitteln bevorzugt in Mengen von 0,05-10 Gew.-%, bezogen auf das gesamte Mittel, enthalten. Mengen von 0,1-5 Gew.-% sind besonders bevorzugt.
• – Vitamin B₆ (Pyridoxin sowie Pyridoxamin und Pyridoxal).

The vitamin B group or the vitamin B complex include, among others

• - Vitamin B ₁ (thiamine)
• - Vitamin B ₂ (riboflavin)
• - Vitamin B ₃ . Under this name, the compounds nicotinic acid and nicotinamide (niacinamide) are often performed. Preferred according to the invention is the nicotinic acid amide, which is preferably contained in the agents according to the invention in amounts of from 0.05 to 1% by weight, based on the total agent.
• - Vitamin B ₅ (pantothenic acid, panthenol and pantolactone). Panthenol and / or pantolactone are preferably used in the context of this group. Derivatives of panthenol which can be used according to the invention are, in particular, the esters and ethers of panthenol and also cationically derivatized panthenols. Individual representatives are for example the Panthenoltriacetat, the Panthenolmonoethylether and its monoacetate as well as in the WO 92/13829 disclosed cationic panthenol derivatives. The said compounds of the vitamin B ₅ type are preferably present in the agents according to the invention in amounts of 0.05-10% by weight, based on the total agent. Amounts of 0.1-5 wt .-% are particularly preferred.
• - Vitamin B ₆ (pyridoxine and pyridoxamine and pyridoxal).

vitamin C (ascorbic acid). Vitamin C is preferably used in amounts of 0.1 to 3 wt .-%, based on the total agent used. The Use in the form of palmitic acid ester, the glucoside or phosphates may be preferred. The usage in combination with tocopherols may also be preferred.

vitamin E (tocopherols, especially α-tocopherol). Tocopherol and its derivatives, including in particular the esters such as the acetate, the nicotinate, the phosphate and the succinate fall, are in the inventive compositions preferably in amounts of 0.05-1% by weight, based on the total agent, contain.

vitamin F. By the term "vitamin F "are usually essential fatty acids, especially linoleic acid, linolenic and arachidonic acid, Understood.

vitamin H. The vitamin H is the compound (3aS, 4S, 6aR) -2-oxohexahydrothienol [3,4-d] imidazole-4-valeric acid, for the But in the meantime, the trivial name Biotin has prevailed. biotin is in the inventive compositions preferably in amounts of 0.0001 to 1.0 wt .-%, in particular in amounts of 0.001 to 0.01 wt .-%.

In summary are agents according to the invention preferred, in addition Contain vitamins and / or pro-vitamins and / or vitamin precursors, which are preferably assigned to the groups A, B, C, E, F and H, preferred agents being in amounts of from 0.1 to 5 wt .-%, preferably from 0.25 to 4 wt .-% and in particular from 0.5 to 2.5% by weight, based in each case on the total agent, contain.

It has been shown that the additional Use of purine and / or purine derivatives in the compositions according to the invention is advantageous because the care performance improves and the hair is strengthened. According to the invention preferred Funds therefore include additional - related on her weight - 0.0005 to 5% by weight of purine and / or purine derivative (s).

Purine (7H-imidazo [4,5-d] pyrimidine) does not occur freely in nature, but forms the main body of purines. Purines, in turn, are a group of important compounds naturally involved in human, animal, plant and microbial metabolic processes which are different from the parent by substitution with OH, NH ₂ , SH at the 2-, 6-, and 8-positions and / or with CH ₃ in 1-, 3-, 7-position derived. Purine can be prepared, for example, from aminoacetonitrile and formamide. Purines and purine derivatives are often isolated from natural products, but are also synthetically accessible in many ways.

preferred inventive agent contain purine and / or purine derivatives in narrower ranges. Here are preferred according to the invention Means characterized in that - based on their weight - 0.001 to 2.5% by weight, preferably 0.0025 to 1% by weight, more preferably 0.005 to 0.5% by weight and in particular 0.01 to 0.1% by weight of purine (s) and / or purine derivative (s).

in der die Reste R¹, R² und R³ unabhängig voneinander ausgewählt sind aus -H, -OH, -NH₂, -SH und die Reste R⁴, R⁵ und R⁶ unabhängig voneinander ausgewählt sind aus -H, -CH₃ und -CH₂-CH₃, wobei folgende Verbindungen bevorzugt sind:

• – Purin(R¹ = R² = R³ = R⁴ = R⁵ = R⁶ = H)
• – Adenin(R¹ = NH₂, R² = R³ = R⁴ = R⁵ = R⁶ = H)
• – Guanin (R¹ = OH, R² = NH₂, R³ = R⁴ = R⁵ = R⁶ = H)
• – Harnsäure(R¹ = R² = R³ = OH, R⁴ = R⁵ = R⁶ = H)
• – Hypoxanthin (R¹ = OH, R² = R³ = R⁴ = R⁵ = R⁶ = H)
• – 6-Purinthiol (R¹ = SH, R² = R³ = R⁴ = R⁵ = R⁶ = H)
• – 6-Thioguanin (R¹ = SH, R² = NH₂, R³ = R⁴ = R⁵ = R⁶ = H)
• – Xanthin (R¹ = R² = OH, R³ = R⁴ = R⁵ = R⁶ = H)
• – Coffein (R¹ = R² = OH, R³ = H, R⁴ = R⁵ = R⁶ = CH₃)
• – Theobromin (R¹ = R² = OH, R³ = R⁴ = H, R⁵ = R⁶ = H)
• – Theophyllin (R¹ = R² = OH, R³ = H, R⁴ = CH₃, R⁵ = CH₃, R⁶ = H)

Among purine, the purines and the purine derivatives, some representatives are particularly preferred according to the invention. Cosmetic agents preferred according to the invention are characterized in that they contain purine and / or purine derivative (s) of the formula (PI)

in which the radicals R ¹ , R ² and R ^{3 are} independently selected from -H, -OH, -NH ₂ , -SH and the radicals R ⁴ , R ⁵ and R ^{6 are} independently selected from -H, -CH ₃ and -CH ₂ -CH ₃ , where the following compounds are preferred:

• Purine (R ¹ = R ² = R ³ = R ⁴ = R ⁵ = R ⁶ = H)
• Adenine (R ¹ = NH ₂ , R ² = R ³ = R ⁴ = R ⁵ = R ⁶ = H)
• Guanine (R ¹ = OH, R ² = NH ₂ , R ³ = R ⁴ = R ⁵ = R ⁶ = H)
• Uric acid (R ¹ = R ² = R ³ = OH, R ⁴ = R ⁵ = R ⁶ = H)
• Hypoxanthine (R ¹ = OH, R ² = R ³ = R ⁴ = R ⁵ = R ⁶ = H)
• 6-purethiol (R ¹ = SH, R ² = R ³ = R ⁴ = R ⁵ = R ⁶ = H)
• 6-thioguanine (R ¹ = SH, R ² = NH ₂ , R ³ = R ⁴ = R ⁵ = R ⁶ = H)
• Xanthine (R ¹ = R ² = OH, R ³ = R ⁴ = R ⁵ = R ⁶ = H)
• Caffeine (R ¹ = R ² = OH, R ³ = H, R ⁴ = R ⁵ = R ⁶ = CH ₃ )
• - Theobromine (R ¹ = R ² = OH, R ³ = R ⁴ = H, R ⁵ = R ⁶ = H)
• Theophylline (R ¹ = R ² = OH, R ³ = H, R ⁴ = CH ₃ , R ⁵ = CH ₃ , R ⁶ = H)

ever after desired Purpose of the agent may vary the nature and amount of purine derivative. Caffeine is particularly important in hair cosmetic formulations proven, for example, in shampoos preferably in amounts of 0.005 to 0.25 wt .-%, more preferably from 0.01 to 0.1 wt .-% and in particular from 0.01 to 0.05 wt .-% (in each case based on the shampoo) used can be.

• – Monosachhariden, insbesondere
• – D-Ribose und/oder
• – D-Xylose und/oder
• – L-Arabinose und/oder
• – D-Glucose und/oder
• – D-Mannose und/oder
• – D-Galactose und/oder
• – D-Fructose und/oder
• – Sorbose und/oder
• – L-Fucose und/oder
• – L-Rhamnose
• – Disacchariden, insbesondere
• – Saccharose und/oder
• – Maltose und/oder
• – Lactose und/oder
• – Trehalose und/oder
• – Cellobiose und/oder
• – Gentiobiose und/oder
• – Isomaltose.

As a further component, the agents according to the invention may contain at least one carbohydrate from the group of monosaccharides, disaccharides and / or oligosaccharides. Here, preferred agents according to the invention are characterized in that they contain from 0.05 to 4.5% by weight, preferably from 0.1 to 4% by weight, particularly preferably from 0.5 to 3.5% by weight and in particular 0, 75 to 2.5 wt .-% carbohydrate (s) containing preferred carbohydrates are selected from

• - Monosaccharides, in particular
• D-ribose and / or
• - D-xylose and / or
• - L-arabinose and / or
• D-glucose and / or
• - D-mannose and / or
• D-galactose and / or
• - D-fructose and / or
• - sorbose and / or
• - L-fucose and / or
• - L-rhamnose
• - Disaccharides, in particular
• - sucrose and / or
• - maltose and / or
• - lactose and / or
• - Trehalose and / or
• Cellobiose and / or
• - Gentiobiose and / or
• - Isomaltose.

• – 0,005 bis 0,015 Gew.-% Coffein und 0,75 bis 1,5 Gew.-% Glucosemonohydrat,
• – 0,005 bis 0,015 Gew.-% Coffein und 0,75 bis 1,5 Gew.-% Saccharose,
• – 0,005 bis 0,015 Gew.-% Coffein und 0,75 bis 1,5 Gew.-% Fructose.

Particularly preferred agents according to the invention contain based on their weight

• 0.005 to 0.015% by weight of caffeine and 0.75 to 1.5% by weight of glucose monohydrate,
• 0.005 to 0.015% by weight of caffeine and 0.75 to 1.5% by weight of sucrose,
• 0.005 to 0.015% by weight of caffeine and 0.75 to 1.5% by weight of fructose.

As a further ingredient, the compositions of the invention may with particular preference one or more contain more amino acids. Amino acids which can be used particularly preferably according to the invention are selected from the group glycine, alanine, valine, leucine, isoleucine, phenylalanine, tyrosine, tryptophan, proline, aspartic acid, glutamic acid, asparagine, glutamine, serine, threonine, cysteine, methionine, lysine, arginine, histidine, β Alanine, 4-aminobutyric acid (GABA), betaine, L-cystine (L-Cyss), L-carnitine, L-citrulline, L-theanine, 3 ', 4'-dihydroxy-L-phenylalanine (L-dopa), 5'-hydroxy-L-tryptophan, L-homocysteine, S-methyl-L-methionine, S-allyl-L-cysteine-sulfoxide (L-alliin), L-trans-4-hydroxyproline, L-5-oxoproline ( L-pyroglutamic acid), L-phosphoserine, creatine, 3-methyl-L-histidine, L-ornithine, whereby both the individual amino acids and mixtures can be used.

preferred inventive agent contain one or more amino acids in narrower ranges. Here are preferred according to the invention Composition characterized in that it additionally contains - 0.05 to 5 wt .-%, preferably 0.1 to 2.5 wt .-%, particularly preferably 0.15 to 1 wt .-% and in particular 0.2 up to 0.5% by weight of amino acid (s), preferably (an) amino acid (s) from the group glycine and / or alanine and / or valine and / or lysine and / or serine and / or proline and / or cysteine and / or leucine and / or threoni.

• – 0,005 bis 0,015 Gew.-% Coffein und 0,75 bis 1,5 Gew.-% Glucosemonohydrat und 0,1 bis 0,25 Gew.-% Glycin,
• – 0,005 bis 0,015 Gew.-% Coffein und 0,75 bis 1,5 Gew.-% Saccharose und 0,1 bis 0,25 Gew.-% Glycin,
• – 0,005 bis 0,015 Gew.-% Coffein und 0,75 bis 1,5 Gew.-% Fructose und 0,1 bis 0,25 Gew.-% Glycin,
• – 0,005 bis 0,015 Gew.-% Coffein und 0,75 bis 1,5 Gew.-% Glucosemonohydrat und 0,1 bis 0,25 Gew.-% Alanin,
• – 0,005 bis 0,015 Gew.-% Coffein und 0,75 bis 1,5 Gew.-% Saccharose und 0,1 bis 0,25 Gew.-% Alanin,
• – 0,005 bis 0,015 Gew.-% Coffein und 0,75 bis 1,5 Gew.-% Fructose und 0,1 bis 0,25 Gew.-% Alanin,
• – 0,005 bis 0,015 Gew.-% Coffein und 0,75 bis 1,5 Gew.-% Glucosemonohydrat und 0,1 bis 0,25 Gew.-% Valin,
• – 0,005 bis 0,015 Gew.-% Coffein und 0,75 bis 1,5 Gew.-% Saccharose und 0,1 bis 0,25 Gew.-% Valin,
• – 0,005 bis 0,015 Gew.-% Coffein und 0,75 bis 1,5 Gew.-% Fructose und 0,1 bis 0,25 Gew.-% Valin.

Particularly preferred agents according to the invention contain based on their weight

• 0.005 to 0.015% by weight of caffeine and 0.75 to 1.5% by weight of glucose monohydrate and 0.1 to 0.25% by weight of glycine,
• 0.005 to 0.015% by weight of caffeine and 0.75 to 1.5% by weight of sucrose and 0.1 to 0.25% by weight of glycine,
• 0.005 to 0.015% by weight of caffeine and 0.75 to 1.5% by weight of fructose and 0.1 to 0.25% by weight of glycine,
• 0.005 to 0.015% by weight of caffeine and 0.75 to 1.5% by weight of glucose monohydrate and 0.1 to 0.25% by weight of alanine,
• 0.005 to 0.015% by weight of caffeine and 0.75 to 1.5% by weight of sucrose and 0.1 to 0.25% by weight of alanine,
• 0.005 to 0.015% by weight of caffeine and 0.75 to 1.5% by weight of fructose and 0.1 to 0.25% by weight of alanine,
• 0.005 to 0.015% by weight of caffeine and 0.75 to 1.5% by weight of glucose monohydrate and 0.1 to 0.25% by weight of valine,
• 0.005 to 0.015% by weight of caffeine and 0.75 to 1.5% by weight of sucrose and 0.1 to 0.25% by weight of valine,
• 0.005 to 0.015% by weight of caffeine and 0.75 to 1.5% by weight of fructose and 0.1 to 0.25% by weight of valine.

enthalten.Preference is also given to the additional use of bisabolol and / or bisabolol oxides in the agents according to the invention. Here, cosmetic agents according to the invention are preferred which additionally contain 0.001 to 5% by weight, preferably 0.01 to 4% by weight, particularly preferably 0.02 to 2.5% by weight and in particular 0.1 to 1.5 % By weight of bisabolol and / or oxides of bisabolol, preferably (-) - alpha-bisabolol

contain.

Farther can in a preferred embodiment the invention also an agent according to the invention UV filter (I) included. The invention to be used UV filters are subject in terms of their structure and their physical Features no general restrictions. Rather, they are suitable all UV filters that can be used in the cosmetics sector, their absorption maximum in the UVA (315-400 nm), in the UVB (280-315 nm) or in the UVC (<280 nm) range. UV filter with an absorption maximum in the UVB range, in particular in the range from about 280 to about 300 nm, are particularly preferred.

The used according to the invention UV filters can for example, selected are substituted benzophenones, p-aminobenzoic acid esters, diphenylacrylates, cinnamic, salicylates, Benzimidazoles and o-aminobenzoic acid esters.

Examples of UV filters which can be used according to the invention are 4-aminobenzoic acid, N, N, N-trimethyl-4- (2-oxoborn-3-ylidenemethyl) aniline-methylsulfate, 3,3,5-trimethyl-cyclohexylsalicylate (homosalates), 2-Hy droxy-4-methoxy-benzophenone (benzophenone-3; Uvinul ^® M 40, Uvasorb MET ^{®, ®} Neo Heliopan BB, Eusolex ^® 4360), 2-phenylbenzimidazole-5-sulfonic acid and potassium, sodium and triethanolamine salts (Phenylbenzimidazole sulfonic acid; Parsol ^® HS; Neo Heliopan Hydro ^®), 3,3 '- (1,4-phenylenedimethylene) -bis (7,7-dimethyl-2-oxo-bicyclo [2.2.1] hept-1-yl methane-sulfonic acid) and salts thereof, 1- (4-tert-butylphenyl) -3- (4-methoxyphenyl) Methoxydibenzoylmethane -propane-1,3-dione (butyl; Parsol ^® 1789 Eusolex ^® 9020), α- ( 2-oxoborn-3-ylidene) toluene-4-sulfonic acid and salts thereof, ethoxylated 4-aminobenzoic acid ethyl ester (PEG-25 PABA; Uvinul ^® P 25), 4-dimethylaminobenzoic acid 2-ethylhexyl (octyl dimethyl PABA; Uvasorb ^® DMO, Escalol ^® 507, Eusolex ^® 6007), salicylic acid 2-ethylhexyl (octyl salicylate; Escalol ^® 587, Neo Heliopan ^® OS, Uvinul ^® O18), 4-methoxycinnamic acid isopentyl (isoamyl p-methoxycinnamate; Neo Heliopan ^® e 1000 ), 4-methoxycinnamic acid 2-ethylhexyl-es ter (octyl methoxycinnamate; Parsol ^® MCX, Escalol ^® 557, Neo Heliopan AV ^®), 2-hydroxy-4-methoxybenzophenone-5-sulfonic acid and its sodium salt (Benzophenone-4; Uvinul ^® MS 40; Uvasorb S 5 ^®), 3- (4'- methylbenzylidene) -D, L-camphor (4-methylbenzylidene camphor; Parsol ^® 5000, Eusolex ^® 6300), 3-benzylidene camphor (3-benzylidene camphor), 4-isopropylbenzyl, 2,4,6-trianilino- (p- carbo-2'-ethylhexyl-1'-oxi) -1,3,5-triazine, 3-imidazol-4-yl-acrylic acid and its ethyl ester, polymers of N - {(2 and 4) - [2-oxoboronyl] 3-ylidenemethyl] benzyl} -acrylamids, 2,4-dihydroxy (benzophenone-1; Uvasorb ^® 20 H, Uvinul ^® 400), 1,1'-Diphenylacrylonitrilsäure-2-ethylhexyl ester (Octocrylene; Eusolex ^® OCR, Neo Heliopan ^® Type 303, Uvinul ^® N 539 SG), o-aminobenzoic acid menthyl ester (menthyl Anthranilate; Neo Heliopan MA ^®), 2,2 ', 4,4'-tetrahydroxy benzophenone (benzophenone-2; Uvinul ^® D-50), 2 '2'-dihydroxy-4,4'-dimethoxybenzophenone (benzophenone-6), 2,2'-dihydroxy-4,4'-dimethoxybenzophenone-5-sodium sulfonate and 2-cyano-3,3-diphenylacrylate 2'-ethylhexyl acrylate. Preference is given to 4-aminobenzoic acid, N, N, N-trimethyl-4- (2-oxoborn-3-ylidenemethyl) aniline methylsulfate, 3,3,5-trimethylcyclohexyl salicylate, 2-hydroxy-4-methoxybenzophenone , 2-phenylbenzimidazole-5-sulfonic acid and its potassium, sodium and triethanolamine salts, 3,3 '- (1,4-phenylenedimethylene) -bis (7,7-dimethyl-2-oxo-bicyclo- [2.2.1] hept-1-yl-methanesulfonic acid) and its salts, 1- (4-tert-butylphenyl) -3- (4-methoxyphenyl) -propane-1,3-dione, α- (2-oxoborn-3-yl) yliden) -toluene-4-sulfonic acid and its salts, ethoxylated 4-aminobenzoic acid ethyl ester, 2-ethylhexyl 4-dimethylaminobenzoate, 2-ethylhexyl salicylate, isopentyl 4-methoxycinnamate, 2-ethylhexyl 4-methoxycinnamate, 2 -Hydroxy-4-methoxybenzophenone-5-sulfonic acid and its sodium salt, 3- (4'-methylbenzylidene) -D, L-camphor, 3-benzylidene-camphor, 4-isopropylbenzylsalicylate, 2,4,6-trianilino- (p-) carbo-2'-ethylhexyl-1'-oxi) -1,3,5-triazine, 3-imidazol-4-yl-acrylic acid and its ethyl ester, polymers of N - {(2 and 4) - [2 -oxoborn-3-ylidene] benzyl} acrylamide. Very particularly preferred according to the invention are 2-hydroxy-4-methoxybenzophenone, 2-phenylbenzimidazole-5-sulfonic acid and its potassium, sodium and triethanolamine salts, 1- (4-tert-butylphenyl) -3- (4-methoxyphenyl) -propane-1,3-dione, 4-methoxycinnamic acid 2-ethylhexyl ester and 3- (4'-methylbenzylidene) -D, L-camphor.

Prefers are those UV filters whose molar extinction coefficient at the absorption maximum above 15,000, especially above 20,000.

Farther was found that at structurally similar UV filters in many cases the water-insoluble Compound in the context of the teaching of the invention, the higher effect across from such water-soluble Compounds that are distinguished from it by one or more additionally distinguish ionic groups. As water-insoluble are within the scope of the invention to understand those UV filters which at 20 ° C to not more than 1 wt .-%, in particular not more than 0.1% by weight, dissolve in water. Farther should these compounds in usual cosmetic oil components at room temperature to at least 0.1, in particular at least 1% by weight soluble be). The use of water-insoluble UV filter can therefore preferred according to the invention be.

According to one another embodiment the invention, those UV filters are preferred which are cationic Group, in particular a quaternary Ammonium group.

These UV filters have the general structure U-Q.

• – substituierte Benzophenone,
• – p-Aminobenzoesäureester,
• – Diphenylacrylsäureester,
• – Zimtsäureester,
• – Salicylsäureester,
• – Benzimidazole und
• – o-Aminobenzoesäureester.

The structural part U stands for a UV-absorbing group. This group can in principle be derived from the known UV filters which can be used in the cosmetics sector, in which a group, generally a hydrogen atom, of the UV filter is replaced by a cationic group Q, in particular having a quaternary amino function , Compounds from which the structural part U can derive are, for example

• Substituted benzophenones,
• P-aminobenzoic acid ester,
• - diphenylacrylic acid ester,
• - cinnamic acid ester,
• Salicylic acid ester,
• Benzimidazoles and
• O-aminobenzoic acid ester.

structural parts U, derived from cinnamamide or derive from N, N-dimethylamino-benzoic acid amide are preferred according to the invention.

The Structural parts U can chosen in principle be that Absorption maximum of the UV filter both in the UVA (315-400 nm) -, as well as in the UVB (280-315nm) - or in the UVC (<280 nm) range. UV filter with an absorption maximum in the UVB range, in particular in the range from about 280 to about 300 nm, are particularly preferred.

Farther is the structural part U, also in dependence on structural part Q, preferably chosen that the molar extinction coefficient of the UV filter at the absorption maximum above 15,000, especially above 20,000.

Of the Structure part Q contains as a cationic group, a quaternary ammonium group is preferred. This quaternary ammonium group can in principle be connected directly to the structural part U, so that the Structural part U one of the four substituents of the positively charged Represents nitrogen atom. However, one of the four is preferred Substituents on the positively charged nitrogen atom is a group, in particular an alkylene group having 2 to 6 carbon atoms, which as a compound between the structural part U and the positively charged nitrogen atom acts.

Advantageously, the group Q has the general structure - (CH ₂ ) _x -N ⁺ R ¹ R ² R ³ X ^- , in which x is an integer from 1 to 4, R ¹ and R ² independently of one another are C _{1 -4} alkyl groups, R ³ is a C _1-22 alkyl group or a benzyl group and X is a physiologically acceptable anion. In the context of this general structure, x preferably represents the number 3, R ¹ and R ² each represent a methyl group and R ^{3 represents} either a methyl group or a saturated or unsaturated, linear or branched hydrocarbon chain having 8 to 22, in particular 10 to 18, carbon atoms.

physiological compatible Anions are, for example, inorganic anions such as halides, in particular chloride, bromide and fluoride, sulfate ions and phosphate ions and organic anions such as lactate, citrate, acetate, tartrate, methosulfate and tosylate.

Two preferred UV filters with cationic groups are the commercially available compounds cinnamic acid trimethyl ammonium chloride (Incroquat ^® UV-283) and dodecyl tosylate (Escalol ^® HP 610).

Of course, the teaching of the invention includes also the use of a combination of several UV filters. in the Frame of this embodiment is the combination of at least one water-insoluble UV filter with at least a UV filter with a cationic group is preferred.

The UV filters (I) are customary in the compositions according to the invention in amounts 0.1-5 wt .-%, based on the total agent included. Levels of 0.4-2.5 wt .-% are preferred.

The compositions of the invention may further contain a 2-pyrrolidinone-5-carboxylic acid and its derivatives (J). Preference is given to the sodium, potassium, calcium, magnesium or ammonium salts in which the ammonium ion carries, in addition to hydrogen, one to three C ₁ - to C ₄ -alkyl groups. The sodium salt is most preferred. The amounts used in the compositions according to the invention are preferably 0.05 to 10 wt .-%, based on the total agent, particularly preferably 0.1 to 5, and in particular 0.1 to 3 wt .-%.

Finally, the agents according to the invention also contain plant extracts (L).

Usually These extracts are produced by extraction of the whole plant. It may, however, in individual cases also be preferred, the extracts exclusively from flowers and / or Scroll to produce the plant.

With regard to the plant extracts which can be used according to the invention, particular reference is made to the extracts which are described on page 44 of the 3rd edition of the guideline on the ingredient declaration of cosmetic co-products tel, issued by the Industrieverband Körperpflege- und Waschmittel eV (IKW), Frankfurt, starting table are listed.

According to the invention are available especially the extracts of green Tea, Oak bark, Stinging nettle, Hamamelis, Hops, Henna, Chamomile, Burdock root, horsetail, hawthorn, lime blossom, almond, Aloe vera, spruce needle, horse chestnut, Sandalwood, juniper, coconut, Mango, Apricot, Lime, Wheat, Kiwi, Melon, Orange, Grapefruit, Sage, Rosemary, Birch, Mallow, Meadowfoam, Quendel, Yarrow, Thyme, melissa, hominy, coltsfoot, marshmallow, meristem, ginseng and ginger root preferred.

Especially preferred are the extracts of green tea, oak bark, stinging nettle, Witch hazel, hops, chamomile, burdock root, horsetail, lime blossom, almond, Aloe vera, coconut, mango, Apricot, lime, wheat, kiwi, melon, orange, grapefruit, sage, Rosemary, Birch, Meadowfoam, Quendel, Yarrow, Hauhechel, Meristem, ginseng and ginger root.

All especially for the use according to the invention suitable are the extracts of green tea, almond, aloe vera, Coconut, Mango, apricot, lime, wheat, kiwi and melon.

When Extraction agent for the preparation of said plant extracts can Water, alcohols and mixtures thereof are used. Under the alcohols are lower alcohols such as ethanol and isopropanol, but especially polyhydric alcohols such as ethylene glycol and propylene glycol, both as sole extractant and in mixture with Water, preferably. Plant extracts based on water / propylene glycol in relation to 1:10 to 10: 1 have proven to be particularly suitable.

The Plant extracts can according to the invention both in pure as well as in diluted Form are used. If used in dilute form, they usually contain about 2-80 wt .-% of active substance and as a solvent in their recovery used extraction agent or extractant mixture.

Farther it may be preferred in the inventive compositions of several, especially from two, different plant extracts use.

In addition, can it prove to be advantageous when in the inventive compositions Penetrants and / or swelling agents (M) are included. These include, for example, to count Urea and urea derivatives, guanidine and its derivatives, arginine and its derivatives, water glass, imidazole and its derivatives, histidine and its derivatives, benzyl alcohol, glycerol, glycol and glycol ether, Propylene glycol and propylene glycol ether, for example propylene glycol monoethyl ether, Carbonates, bicarbonates, diols and triols, and in particular 1,2-diols and 1,3-diols such as 1,2-propanediol, 1,2-pentanediol, 1,2-hexanediol, 1,2-dodecanediol, 1,3-propanediol, 1,6-hexanediol, 1,5-pentanediol, 1,4-butanediol.

Advantageous in the sense of the invention additionally short-chain carboxylic acids (N) support the drug complex (A). Under short-chain carboxylic acids and their derivatives in the context of the invention are understood to mean carboxylic acids, which is saturated or unsaturated and / or straight-chain or branched or cyclic and / or aromatic and / or may be heterocyclic and have a molecular weight less than 750. Preferred in the sense of the invention saturated or unsaturated straight-chain or branched carboxylic acids having a chain length of 1 to 16 carbon atoms in the chain, most preferably are those with a chain length from 1 to 12 C atoms in the chain.

The short-chain carboxylic acids according to the invention may have one, two, three or more carboxy groups. Preferred within the meaning of the invention are carboxylic acids having a plurality of carboxy groups, in particular di- and tricarboxylic acids. The carboxy groups may be wholly or partly present as esters, acid anhydride, lactone, amide, imidic acid, lactam, lactim, dicarboximide, carbohydrazide, hydrazone, hydroxam, hydroxime, amidine, amidoxime, nitrile, phosphonic or phosphate ester. The carboxylic acids used according to the invention may of course be substituted along the carbon chain or the ring skeleton. The substituents of the carboxylic acids used according to the invention include, for example, C 1 -C 8 -alkyl, C 2 -C 8 -alkenyl, aryl, aralkyl and aralkenyl, hydroxymethyl, C 2 -C 8 -hydroxyalkyl, C 2 -C 8 -hydroxyalkenyl , Aminomethyl, C 2 -C 8 -aminoalkyl, cyano, formyl, oxo, thioxo, hydroxy, mercapto, amino, carboxy or imino groups. Preferred substituents are C 1 -C 8 alkyl, hydroxymethyl, hydroxy, amino and carboxy groups. Particular preference is given to substituents in the ⎕-position. Very particularly preferred substituents are hydroxy, alkoxy and amino groups, where the amino function may optionally be further substituted by alkyl, aryl, aralkyl and / or alkenyl radicals. Furthermore, preferred are also Carbonsäu rederivate the phosphonic and phosphate esters.

in der Z steht für eine lineare oder verzweigte Alkyl- oder Alkenylgruppe mit 4 bis 12 Kohlenstoffatomen, n für eine Zahl von 4 bis 12 sowie eine der beiden Gruppen X und Y für eine COOH-Gruppe und die andere für Wasserstoff oder einen Methyl- oder Ethylrest, Dicarbonsäuren der allgemeinen Formel (N-I), die zusätzlich noch 1 bis 3 Methyl- oder Ethylsubstituenten am Cyclohexenring tragen sowie Dicarbonsäuren, die aus den Dicarbonsäuren gemäß Formel (N-I) formal durch Anlagerung eines Moleküls Wasser an die Doppelbindung im Cyclohexenring entstehen.Examples of carboxylic acids according to the invention include formic acid, acetic acid, propionic acid, butyric acid, isobutyric acid, valeric acid, isovaleric acid, pivalic acid, oxalic acid, malonic acid, succinic acid, glutaric acid, glyceric acid, glyoxylic acid, adipic acid, pimelic acid, suberic acid, sebacic acid, propiolic acid, crotonic acid, isocrotonic acid , Elaidic, maleic, fumaric, muconic, citraconic, mesaconic, camphoric, benzoic, o, m, p-phthalic, naphthoic, toluoic, hydratropic, atropic, cinnamic, isonicotinic, nicotinic, bicarbamic, 4,4'-dicyano-6, 6'-binicotinic acid, 8-carbamoyloctanoic acid, 1,2,4-pentanetricarboxylic acid, 2-pyrrolecarboxylic acid, 1,2,4,6,7-naphthalene pentaacetic acid, malonaldehyde acid, 4-hydroxyphthalamic acid, 1-pyrazolecarboxylic acid, gallic acid or propane tricarboxylic acid, a dicarboxylic acid from the group formed by connections de r general formula (NI),

in the Z is a linear or branched alkyl or alkenyl group having 4 to 12 carbon atoms, n is a number from 4 to 12 and one of the two groups X and Y is a COOH group and the other is hydrogen or a methyl or Ethyl radical, dicarboxylic acids of the general formula (NI), which additionally carry 1 to 3 methyl or ethyl substituents on the cyclohexene ring and dicarboxylic acids formed formally from the dicarboxylic acids according to formula (NI) by addition of a molecule of water to the double bond in the cyclohexene ring.

Dicarboxylic acids of Formula (N-I) are known in the literature.

The dicarboxylic acids of the formula (N-I) for example, by reaction of polyunsaturated dicarboxylic acids with unsaturated Monocarboxylic acids in the form of a Diels-Alder cyclization getting produced. Usually one is called by a polyunsaturated fatty acid as Dicarboxylic acid go out. Preferably, the natural Grease and oil accessible Linoleic acid. As monocarboxylic acid component are in particular acrylic acid, but also e.g. methacrylic acid and crotonic acid prefers. Usually occur in reactions according to Diels-Alder isomer mixtures, at which is a component in excess. These isomer mixtures can According to the invention as well how the pure compounds are used.

Usable according to the invention in addition to the preferred dicarboxylic acids according to formula (N-I) are also dicarboxylic acids, from the compounds of the formula (N-I) by 1 to 3 differentiate methyl or ethyl substituents on the cyclohexyl ring or formally from these compounds by addition of one molecule of water be formed on the double formation of the cyclohexene ring.

The dicarboxylic acid (mixture), which is obtained by reacting linoleic acid with acrylic acid, has proved to be particularly effective according to the invention. It is a mixture of 5- and 6-carboxy-4-hexyl-2-cyclohexene-1-octanoic acid. Such compounds are commercially available under the designations Westvaco Diacid 1550 Westvaco Diacid ^{® ®} 1595 (manufacturer: Westvaco).

Next the example listed above used according to the invention short-chain carboxylic acids yourself can also their physiologically compatible Salts used according to the invention become. examples for such salts are the alkali, alkaline earth, zinc salts and ammonium salts, Within the scope of the present application, the mono-, di- and tri methyl, -ethyl and hydroxyethyl ammonium salts to understand are. Very particularly preferred in the context of the invention, however, with alkaline-reacting amino acids, such as For example, arginine, lysine, ornithine and histidine, neutralized acids be used. Furthermore, it may be preferred for formulation reasons be the carboxylic acid from the water-soluble Representatives, in particular the water-soluble salts.

Furthermore, it is preferred according to the invention to use hydroxycarboxylic acids and here again in particular the dihydroxy-, trihydroxy- and polyhydroxycarboxylic acids as well as the dihydroxy, trihydroxy and polyhydroxy di-, tri- and polycarboxylic acids together with the active compound (A). It has been shown in addition to the hydroxycarboxylic acids, the hydroxycarboxylic acid esters and the mixtures of hydroxycarboxylic acids and their esters as well as polymeric hydroxycarboxylic acids and their esters can be very particularly preferred. Preferred hydroxycarboxylic acid esters are, for example, full esters of glycolic acid, lactic acid, malic acid, tartaric acid or citric acid. Further basically suitable hydroxycarboxylic esters are esters of β-hydroxypropionic acid, tartronic acid, D-gluconic acid, sugar acid, mucic acid or glucuronic acid. Suitable alcohol components of these esters are primary, linear or branched aliphatic alcohols having 8-22 C atoms, ie, for example, fatty alcohols or synthetic fatty alcohols. The esters of C12-C15 fatty alcohols are particularly preferred. Esters of this type are commercially available, eg under the trademark Cosmacol® ^® EniChem, Augusta Industriale. Particularly preferred polyhydroxypolycarboxylic acids are polylactic acid and polyuric acid and their esters.

A Particularly preferred group of Inhaltsstofen make the silicones represents.

• (i) Polyalkylsiloxanen, Polyarylsiloxanen, Polyalkylarylsiloxanen, die flüchtig oder nicht flüchtig, geradkettig, verzweigt oder cyclisch, vernetzt oder nicht vernetzt sind;
• (ii) Polysiloxanen, die in ihrer allgemeinen Struktur eine oder mehrere organofunktionelle Gruppen enthalten, die ausgewählt sind unter: a) substituierten oder unsubstituierten aminierten Gruppen; b) (per)fluorierten Gruppen; c) Thiolgruppen; d) Carboxylatgruppen; e) hydroxylierten Gruppen; f) alkoxylierten Gruppen; g) Acyloxyalkylgruppen; h) amphoteren Gruppen; i) Bisulfitgruppen; j) Hydroxyacylaminogruppen; k) Carboxygruppen; l) Sulfonsäuregruppen; und m) Sulfat- oder Thiosulfatgruppen;
• (iii) linearen Polysiloxan(A)-Polyoxyalkylen(B)-Blockcopoylmeren vom Typ (A-B)_n mit n > 3;
• (iv) gepfropften Siliconpolymeren mit nicht siliconhaltigem, organischen Grundgerüst, die aus einer organischen Hauptkette bestehen, welche aus organischen Monomeren gebildet wird, die kein Silicon enthalten, auf die in der Kette sowie gegebenenfalls an mindestens einem Kettenende mindestens ein Polysiloxanmakromer gepfropft wurde;
• (v) gepfropften Siliconpolymeren mit Polysiloxan-Grundgerüst, auf das nicht siliconhaltige, organische Monomere gepfropft wurden, die eine Polysiloxan-Hauptkette aufweisen, auf die in der Kette sowie gegebenenfalls an mindestens einem ihrer Enden mindestens ein organisches Makromer gepfropft wurde, das kein Silicon enthält;

oder deren Gemischen.Preferred agents according to the invention are characterized in that they comprise at least one silicone, preferably a silicone, selected from:

• (i) polyalkyl siloxanes, polyaryl siloxanes, polyalkylaryl siloxanes which are volatile or nonvolatile, straight chain, branched or cyclic, crosslinked or uncrosslinked;
• (ii) polysiloxanes containing in their general structure one or more organofunctional groups selected from: a) substituted or unsubstituted aminated groups; b) (per) fluorinated groups; c) thiol groups; d) carboxylate groups; e) hydroxylated groups; f) alkoxylated groups; g) acyloxyalkyl groups; h) amphoteric groups; i) bisulfite groups; j) hydroxyacylamino groups; k) carboxy groups; l) sulfonic acid groups; and m) sulfate or thiosulfate groups;
• (iii) linear polysiloxane (A) polyoxyalkylene (B) block copolymers of the (AB) _{n type} with n>3;
• (iv) grafted silicone polymers having a non-silicone organic backbone consisting of an organic backbone formed from organic monomers containing no silicone grafted with at least one polysiloxane macromer in the chain and optionally at least one chain end;
• (v) grafted polysiloxane backbone silicone polymers having grafted thereto non-silicone organic monomers having a polysiloxane backbone to which at least one organic macromer not containing silicone has been grafted in the chain, and optionally at least at one of its ends ;

or their mixtures.

Particularly according to the invention preferred agents preferably contain the silicone (s) in amounts of from 0.1 to 10% by weight, preferably from 0.25 to 7% by weight and in particular from 0.5 to 5 wt .-%, each based on the total Medium.

preferred Silicones are described below.

Particularly preferred agents according to the invention are characterized in that they contain at least one silicone of the formula Si-I (CH ₃ ) ₃ Si- [O-Si (CH ₃ ) ₂ ] _x -O-Si (CH ₃ ) ₃ (Si-I), in which x is a number from 0 to 100, preferably from 0 to 50, more preferably from 0 to 20 and in particular 0 to 10.

These silicones are called DIMETHICONE according to the INCI nomenclature. In the context of the present invention, as the silicone of the formula Si-1, the compounds are preferably:
(CH ₃ ) ₃ Si-O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si-O- (CH ₃ ) ₂ Si-O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₂ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₃ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₄ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₅ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₆ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₇ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₈ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₉ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₁₀ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₁₁ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₁₂ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₁₃ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₁₄ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₁₅ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₁₆ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₁₇ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₁₈ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₁₉ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₂₀ -O-Si (CH ₃ ) ₃
where (CH ₃ ) ₃ Si-O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si-O- (CH ₃ ) ₂ Si-O-Si (CH ₃ ) ₃ and / or (CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₂ -O-Si (CH ₃ ) _{3 are} particularly preferred.

Of course you can too Mixtures of the above Silicones in the compositions according to the invention be included.

Preferred silicones which can be used according to the invention have viscosities of from 0.2 to 2 mm ² s ^-1 at 20 ° C., silicones having viscosities of from 0.5 to 1 mm ² s ^{-1 being} particularly preferred.

Particularly preferred agents according to the invention contain one or more amino-functional silicones. Such silicones may, for example, be represented by the formula M (R _a Q _b SiO _{(4-ab) / 2) x} (R _c SiO _{(4-c) / 2) y} M wherein R in the above formula is a hydrocarbon or a hydrocarbon group of 1 to about 6 carbon atoms, Q is a polar group of the general formula -R ¹ HZ wherein R ^{1 is} a divalent linking group attached to hydrogen and the group Z is an organic, amino-functional radical containing at least one amino-functional group, carbon and hydrogen atoms, carbon, hydrogen and oxygen atoms or carbon, hydrogen and nitrogen atoms; "a" assumes values in the range of about 0 to about 2, "b" assumes values in the range of about 1 to about 3, "a" + "b" is less than or equal to 3, and "c" is a number in the range from about 1 to about 3, and x is a number ranging from 1 to about 2,000, preferably from about 3 to about 50, and most preferably from about 3 to about 25, and y is a number ranging from about 20 to about 10,000 , preferably from about 125 to about 10,000, and most preferably from about 150 to about 1,000, and M is a suitable silicone end group as known in the art, preferably trimethylsiloxy. Non-limiting examples of the groups represented by R include alkyl groups such as methyl, ethyl, propyl, isopropyl, isopropyl, butyl, isobutyl, amyl, isoamyl, hexyl, isohexyl and the like; Alkenyl radicals such as vinyl, halovinyl, alkylvinyl, allyl, haloallyl, alkylallyl; Cycloalkyl radicals such as cyclobutyl, cyclopentyl, cyclohexyl and the like; Phenyl radicals, benzyl radicals, halohydrocarbon radicals such as 3-chloropropyl, 4-bromobutyl, 3,3,3-trifluoropropyl, chlorocyclohexyl, bromophenyl, chlorophenyl and the like, and sulfur containing radicals such as mercaptoethyl, mercaptopropyl, mercaptohexyl, mercaptophenyl and the like; preferably R is an alkyl radical containing from 1 to about 6 carbon atoms, and most preferably R is methyl. Examples of R ¹ include methylene, ethylene, propylene, hexamethylene, decamethylene, -CH ₂ CH (CH ₃ ) CH ₂ -, phenylene, naphthylene, -CH ₂ CH ₂ SCH ₂ CH ₂ -, -CH ₂ CH ₂ OCH ₂ - , -OCH ₂ CH ₂ -, -OCH ₂ CH ₂ CH ₂ -, -CH ₂ CH (CH ₃ ) C (O) OCH ₂ -, - (CH ₂ ) ₃ CC (O) OCH ₂ CH ₂ -, C ₆ H ₄ C ₆ H ₄ -, -C ₆ H ₄ CH ₂ C ₆ H ₄ -; and - (CH ₂ ) ₃ C (O) SCH ₂ CH ₂ -.

Z is an organic, amino-functional radical containing at least one functional amino group. A possible formula for Z is NH (CH ₂ ) _z NH ₂ , wherein z is 1 or more. Another possible formula for Z is -NH (CH ₂ ) _z (CH ₂ ) _zz NH, wherein both z and zz are independently 1 or more, which structure includes diamino ring structures, such as piperazinyl. Z is most preferably a -NHCH ₂ CH ₂ NH ₂ radical. Another possible formula for Z is -N (CH ₂ ) (CH ₂ ) _zz NX ₂ or -NX ₂ , wherein each X of X _{2 is} independently selected from the group consisting of hydrogen and alkyl groups of 1 to 12 carbon atoms, and zz 0 is.

Q is most preferably a polar, amine functional group of the formula -CH ₂ CH ₂ CH ₂ NHCH ₂ CH ₂ NH ₂ . In the formulas, "a" assumes values in the range of about 0 to about 2, "b" assumes values in the range of about 2 to about 3, "a" + "b" is less than or equal to 3, and "c "is a number in the range of about 1 to about 3. The molar ratio of the R _a Q _b SiO _{(4-ab) / 2} units to the R _c SiO _{(4-c) / 2} units is in the range of about From 1: 2 to 1:65, preferably from about 1: 5 to about 1: 65, and most preferably from about 1: 15 to about 1: 20. When one or more silicones of the above formula are employed then the various variable substituents in of the above formula may be different for the various silicone components present in the silicone blend.

• – G ist -H, eine Phenylgruppe, -OH, -O-CH₃, -CH₃, -O-CH₂CH₃, -CH₂CH₃, -O-CH₂CH₂CH₃, -CH₂CH₂CH₃, -O-CH(CH₃)₂, -CH(CH₃)₂, -O-CH₂CH₂CH₂CH₃, -CH₂CH₂CH₂CH₃, -O-CH₂CH(CH₃)₂, -CH₂CH(CH₃)₂, -O-CH(CH₃)CH₂CH₃, -H(CH₃)CH₂CH₃, -O-C(CH₃)₃, -C(CH₃)₃;
• – a steht für eine Zahl zwischen 0 und 3, insbesondere 0;
• – b steht für eine Zahl zwischen 0 und 1, insbesondere 1,
• – m und n sind Zahlen, deren Summe (m + n) zwischen 1 und 2000, vorzugsweise zwischen 50 und 150 beträgt, wobei n vorzugsweise Werte von 0 bis 1999 und insbesondere von 49 bis 149 und m vorzugsweise Werte von 1 bis 2000, insbesondere von 1 bis 10 annimmt,
• – R' ist ein monovalenter Rest ausgewählt aus • -Q-N(R'')-CH₂-CH₂-N(R'')₂ • -Q-N(R'')₂ • -Q-N+(R'')₃A^- • -Q-N⁺H(R'')₂A • -Q-N⁺H₂(R'')A • -Q-N(R'')-CH₂-CH₂-N⁺R''H₂A^-, wobei jedes Q für eine chemische Bindung, -CH₂-, -CH₂-CH₂-, -CH₂CH₂CH₂-, -C(CH₃)₂-, -CH₂CH₂CH₂CH₂-, -CH₂C(CH₃)₂-, -CH(CH₃)CH₂CH₂- steht, R'' für gleiche oder verschiedene Reste aus der Gruppe -H, -Phenyl, -Benzyl, -CH₂-CH(CH₃)Ph, der C_1-20-Alkylreste, vorzugsweise -CH₃, -CH₂CH₃, -CH₂CH₂CH₃, -CH(CH₃)₂, -CH₂CH₂CH₂H₃, -CH₂CH(CH₃)₂, -CH(CH₃)CH₂CH₃, -C(CH₃)₃, steht und A ein Anion repräsentiert, welches vorzugsweise ausgewählt ist aus Chlorid, Bromid, Iodid oder Methosulfat.

Preferred agents according to the invention are characterized in that they contain an amino-functional silicone of the formula (Si-II) R ' _a G _3-a -Si (OSiG ₂ ) _n - (OSiG _b R' _2-b ) _m -O-SiG _3-a R ' _a (Si-II), contain, in which means:

• G is -H, a phenyl group, -OH, -O-CH ₃ , -CH ₃ , -O-CH ₂ CH ₃ , -CH ₂ CH ₃ , -O-CH ₂ CH ₂ CH ₃ , -CH ₂ CH ₂ CH ₃ , -O-CH (CH ₃ ) ₂ , -CH (CH ₃ ) ₂ , -O-CH ₂ CH ₂ CH ₂ CH ₃ , -CH ₂ CH ₂ CH ₂ CH ₃ , -O-CH ₂ CH (CH ₃ ) ₂ , -CH ₂ CH (CH ₃ ) ₂ , -O-CH (CH ₃ ) CH ₂ CH ₃ , -H (CH ₃ ) CH ₂ CH ₃ , -OC (CH ₃ ) ₃ , -C (CH ₃ ) ₃ ;
• A is a number between 0 and 3, in particular 0;
• B is a number between 0 and 1, in particular 1,
• M and n are numbers whose sum (m + n) is between 1 and 2000, preferably between 50 and 150, where n is preferably values from 0 to 1999 and in particular from 49 to 149 and m preferably values from 1 to 2000, in particular from 1 to 10,
• R 'is a monovalent radical selected from • -QN (R'') - CH ₂ -CH ₂ -N (R'') ₂ • -QN (R'') ₂ • -Q-N + (R'') ₃ A ^- • -QN ⁺ H (R '') ₂ A • -QN ⁺ H ₂ (R '') A • -QN (R '') - CH ₂ -CH ₂ -N ⁺ R''H ₂ A ^- , wherein each Q is a chemical bond, -CH ₂ -, -CH ₂ -CH ₂ -, -CH ₂ CH ₂ CH ₂ -, -C (CH ₃ ) ₂ -, -CH ₂ CH ₂ CH ₂ CH ₂ -, CH ₂ C (CH ₃ ) ₂ -, -CH (CH ₃ ) CH ₂ CH ₂ -, R '' is identical or different radicals from the group -H, -phenyl, -benzyl, -CH ₂ - CH (CH ₃ ) Ph, the C _1-20 -alkyl radicals, preferably -CH ₃ , -CH ₂ CH ₃ , -CH ₂ CH ₂ CH ₃ , -CH (CH ₃ ) ₂ , -CH ₂ CH ₂ CH ₂ H ₃ , -CH ₂ CH (CH ₃ ) ₂ , -CH (CH ₃ ) CH ₂ CH ₃ , -C (CH ₃ ) ₃ , and A represents an anion, which is preferably selected from chloride, bromide, iodide or methosulfate ,

enthalten, worin m und n Zahlen sind, deren Summe (m + n) zwischen 1 und 2000, vorzugsweise zwischen 50 und 150 beträgt, wobei n vorzugsweise Werte von 0 bis 1999 und insbesondere von 49 bis 149 und m vorzugsweise Werte von 1 bis 2000, insbesondere von 1 bis 10 annimmt.Particularly preferred agents according to the invention are characterized in that they contain at least one amino-functional silicone of the formula (Si-IIa)

in which m and n are numbers whose sum (m + n) is between 1 and 2000, preferably between 50 and 150, where n preferably values of 0 to 1999 and in particular of 49 to 149 and m preferably values of 1 to 2000 , in particular from 1 to 10 assumes.

These Silicones are classified as trimethylsilylamodimethicones according to the INCI declaration designated.

enthalten, worin R für -OH, -O-CH₃ oder eine -CH₃-Gruppe steht und m, n1 und n2 Zahlen sind, deren Summe (m + n1 + n2) zwischen 1 und 2000, vorzugsweise zwischen 50 und 150 beträgt, wobei die Summe (n1 + n2) vorzugsweise Werte von 0 bis 1999 und insbesondere von 49 bis 149 und m vorzugsweise Werte von 1 bis 2000, insbesondere von 1 bis 10 annimmt.Also particularly preferred are agents according to the invention which are an amino-functional silicone of the formula (Si-IIb)

in which R is -OH, -O-CH ₃ or a -CH ₃ group and m, n1 and n2 are numbers whose sum (m + n1 + n2) is between 1 and 2,000, preferably between 50 and 150 , where the sum (n1 + n2) preferably assumes values from 0 to 1999 and in particular from 49 to 149 and m preferably values from 1 to 2000, in particular from 1 to 10.

These Silicones are called amodimethicones according to the INCI declaration.

Independently of, which amino-functional silicones are used are agents according to the invention preferably containing an amino-functional silicone whose amine number above 0.25 meq / g, preferably above 0.3 meq / g and especially above 0.4 meq / g. The amine number stands for the milliequivalents Amine per gram of amino-functional silicone. It can be done by titration determined and also in the unit mg KOH / g.

According to the invention preferred Agents are characterized by being 0.01% by weight to 10% by weight, preferably 0.1 to 8% by weight, more preferably 0.25 to 7.5% by weight and in particular 0.5 to 5% by weight of amino-functional (s) Silicone (s) included.

The INCI CYCLOMETHICONE designated cyclic dimethicones are inventively used with preference. Here, agents according to the invention are preferred which contain at least one silicone of the formula Si-III- [O-Si (CH ₃ ) ₂ ] _x - (Si-III) in which x is a number from 3 to 200, preferably from 3 to 10, more preferably from 3 to 7 and in particular 3, 4, 5 or 6 stands.

The silicones described above have a backbone consisting of -Si-O-Si units is constructed. Of course can these Si-O-Si units may also be interrupted by carbon chains. Appropriate molecules are by chain extension reactions accessible and preferably come in the form of silicone-in-water emulsions for use.

Agents of the invention which are likewise preferred are characterized in that they contain at least one silicone of the formula Si-IV R ₃ Si [O-SiR ₂ ] _x - (CH ₂ ) _n - [O-SiR ₂ ] _y -O-SiR ₃ (Si-IV), in which R is identical or different radicals from the group -H, -phenyl, -benzyl, -CH ₂ -CH (CH ₃ ) Ph, the C _1-20 -alkyl radicals, preferably -CH ₃ , -CH ₂ CH ₃ , -CH ₂ CH ₂ CH ₃ , -CH (CH ₃ ) ₂ , -CH ₂ CH ₂ CH ₂ H ₃ , -CH ₂ CH (CH ₃ ) ₂ , -CH (CH ₃ ) CH ₂ CH ₃ , - C (CH ₃ ) ₃ , x and y are a number from 0 to 200, preferably from 0 to 10, more preferably from 0 to 7 and especially 0, 1, 2, 3, 4, 5 or 6, stand and n is a number from 0 to 10, preferably from 1 to 8 and in particular from 2, 3, 4, 5, 6.

With The silicones are preferably water-soluble. According to the invention preferred Means are characterized in that they contain at least one water-soluble Silicone included.

It is also preferred, the agents according to the invention special care agents added, which support the effect of the complexing agents according to the invention. Here have particular orange oil and extracts of rock crystal proven.

Orange oil, too known as orange peel oil (lat. Aurantii dulcis Aetheroleum) becomes from the shells of the more mature fruit obtained by steam distillation and consists mainly of D-limonene. Main areas of origin are Brazil, California, Florida and Sicily.

Surprisingly it was found that finely milled quartz as well as an extract from finely ground quartz in the inventive compositions in excellent Way, to give the skin and hair a velvety, soft, pleasant feeling to rent. Furthermore, the shine of skin and hair in excellent Manner significantly increased. However, there is no undesirable stress on the skin and Hair. Also on the hair are subsequent treatments such as cold wave or dyeing processes not only not adversely affected but it finds no impairment instead of.

The finely ground quartz, the quartz powder according to the invention is obtained by conventional methods for crushing and grinding of rocks. Quartz powder is used especially in particle sizes from 0.5 μm up to 500 μm. Particular preference is given to particle sizes of from 0.5 to 250 μm, very particularly preferably from 10 μm to 200 μm. In a preferred embodiment of the invention, the finely ground quartz is extracted by means of erotic solvents and the resulting quartz extract is used in the cosmetic compositions. Also in this embodiment are quartz, tridymite, cristobalite, keatite, coesite, stishovite, rock crystal, smoky quartz, amethyst, chrysoprase, citrine, morion, roses quartz, opal and its varieties agate, chalcedony, onyx, carnelian, heliotrope, jasper or flint are used as starting materials for the preparation of a flour and the subsequent extraction to the "quartz extract." Preference is given to quartz, smoky quartz, rock crystal, rose quartz and agate Smoky quartz, rose quartz and rock crystal are preferred, most preferably rock crystal.

As extraction agent for the preparation of said quartz extracts, water, alcohols and mixtures thereof can be used. Underwater are to be understood here as demineralized water, as well as seawater and mineral water. Among the alcohols are lower alcohols such as ethanol, isopropanol, butanol, isobutanol, tert-butanol, pentanols, hexanols or heptanols, but especially polyhydric alcohols such as glycerols and glycols, in particular glycol, diglycol, glycerol, diglycerol, triglycerol, polyglycerol , Ethylene glycol, propylene glycol and butylene glycol both as the sole extractant and in admixture with demineralized water, mineral water or seawater. Extracts based on water and polyhydric alcohols in the ratio 1:50 to 50: 1 have proved to be suitable according to the invention. A ratio of 1:25 to 25: 1 is preferred. Particularly preferred is a ratio of 1:10 to 10: 1. Most preferred is a ratio of 1: 5 to 5: 1, with a ratio of water to polyhydric alcohol of 3: 1 to 1: 1 being most preferred. The invention also includes the teaching that, of course, a plurality of alcohols and / or polyhydric alcohols can be used as extractant in admixture with water. Under mineral water is to understand water, which comes naturally from mineralized sources. For example, the mineral waters include Evian, SpA, Léau de Vichy, etc. As the extraction method, any known methods such as hot extraction or other methods may be used. A quartz extract thus obtained usually contains at least 1 to 100,000 ppm of silicon. Preferred is an extract with a minimum amount of silicon of 10 ppm. Particularly preferred is an extract with a content of silicon of at least 50 ppm. Very particular preference is given to an extract with a content of at least 100 ppm. Most preferred is a content of at least 200 ppm silicon. The amount of silicon in the extract is determined by flame spectrometry in distilled water. The quartz extract may optionally be adjusted with water glass to a constant minimum content of silicon. If water glass is used to set a constant silicon content, it may still be necessary to adjust the pH of the quartz extract. The quartz extract usually has a pH of 4-11, preferably 6-11, more preferably 7-10 and most preferably 7.5-9.5. Should it be necessary to adjust the pH of the quartz extract, the pH will be adjusted with mineral acids such as aqueous solutions of hydrogen halides, sulfuric acid and its salts, sulphurous acid and its salts, phosphorous acid and its salts, phosphoric acid and its salts or with organic acids Acids and their salts such as iminodisuccinic acid, etidronic acid, tartaric acid or citric acid made. The adjustment of the pH of the quartz extract with acids, which also have complex-forming properties, may be preferred. These include, for example, phosphoric acid, iminodisuccinic acid, etidronic acid, tartaric acid or citric acid and their salts. Very particular preference is given to using phosphoric acid in the case of a necessary pH adjustment. An example of a commercially available quartz extract is available under the name Crodarom ^® rock crystal by Croda free in the trade.

In addition, the shading compositions of the invention may contain one or more substantive dyes. Direct dyes are usually nitrophenylenediamines, nitroaminophenols, azo dyes, anthraquinones or indophenols, triphenylmethane dyes, acid dyes, basic dyes, preferably from the group of the international trade names HC Yellow 2, HC Yellow 4, HC Yellow 5, HC Yellow 6, HC Yellow 12, Acid Yellow 1, Acid Yellow 1, Acid Yellow 23, Acid Yellow 36, HC Orange 1, Disperse Orange 3, Acid Orange 7, HC Red 1, HC Red 3, HC Red 10, HC Red 11, HC Red 13, Acid Red 33, Acid Red 52, Acid Red 92, HC Red BN, Pigment Red 57: 1, HC Blue 2, HC Blue 12, Disperse Blue 3, Disperse Red 17, Acid Blue 7, Acid Green 50, HC Violet 1, Disperse Violet 1, Disperse Violet 4, Acid Violet 43, Disperse Black 9, Acid Black 1, and Acid Black 52 known compounds as well as 1,4-diamino-2-nitrobenzene, 2-amino-4-nitrophenol , 1,4-bis (β-hydroxyethyl) amino-2-nitrobenzene, 3-nitro-4- (β-hydroxyethyl) aminophenol, 2- (2-hydroxyethyl) amino-4,6-di nitrophenol, 1- (2'-hydroxyethyl) amino-4-methyl-2-nitrobenzene, 1-amino-4- (2-hydroxyethyl) amino-5-chloro-2-nitrobenzene, 4-amino-3-nitrophezol, 1- (2-Ureidoethyl) amino-4-nitrobenzene, 4-amino-2-nitrodiphenylamine-2'-carboxylic acid, 6-nitro-1,2,3,4-tetrahydroquinoxaline, 2-hydroxy-1,4-naphthoquinone, Picramic acid and its salts, 2-amino-6-chloro-4-nitrophezol, 4-ethylamino-3-nitrobenzoic acid and 2-chloro-6-ethylamino-1-hydroxy-4-nitrobenzene, 3- (2 ', 6'- Diaminopyridyl-3'-azo) pyridine; 2 - ((4- (ethyl (2-hydroxyethyl) amino) -2-methylphenyl) azo) -5-nitro-1,3-thiazole; N, N-di (2-hydroxyethyl) -3-methyl-4 - ((4-nitrophenyl) azo) -aniline; 3-diethylamino-7- (4-dimethylaminophenylaz0) -5-phenyl-phenazinium chloride; 4- (2-thiazolylazo) resorcinol; 4 - (((4-phenylamino) azo) benzosulfonic acid, sodium salt, 1 - ((3-aminopropyl) amino) -9, 10-anthracendione, 3 ', 3'',4,5,5', 5 '', 6,7-octabromophenolsulfonephthalein; 1 - ((4-amino-3,5-dimethylphenyl) - (2,6-dichlorophenyl) methyl len) -3,5-dimethyl-4-imino-2,5-cyclohexadiene-phosphoric acid (1: 1) (Basic Blue 77); 3 ', 3'',5', 5 '' - tetrabromo-m-kresolsulfonphthalein; 2,4-dinitro-1-naphthol-7-sulfonic acid disodium salt; 4- [2'-hydroxy-1'-naphthyl) azo] benzenesulfonic acid sodium salt; 3 ', 6'-dihydroxy-2', 41I51I71-tetraiodospiro- [isobenzo-furan-1 (3H), g1 (9H) -xanthenl-3-one disodium salt; 6-hydroxy-5 - ((2-methoxy-5-methyl-4-sulfophenyl) azo) -2-naphthalene-sulfonic acid disodium salt; 2,4-dinitro-Inaphthol sodium salt; 2 ', 4', 5 ', 7'-tetrabromo-4151617-tetrachloro-3'16'-dihydroxy-spiro [isobenzofuran-I (3H), 9' [9H] xanthene] -3-one disodium salt; 4- (2-hydroxy-I-naphthylazo) -3-methylbenzolsulfonsäurenatriumsalz; Basic Orange 31, Basic Blue 6, Basic Blue 7, Basic Blue 9, Basic Blue 26, Basic Blue 41, Basic Blue 99, Basic Brown 4, Basic, Brown 16, Basic Brown 17, Natural Brown 7, Basic Green 1, Basic Red 2, Basic Red 12 Basic Red 22, Basic Red 51, Basic Red 76, Basic Violet 1, Basic Violet 2, Basic Violet 3, Basic Violet 10, Basic Violet 14, Basic Yellow 57, Basic Yellow 87, Basic Red 46.

According to the invention preferred Means characterized in that they additionally - based on its weight - 0.001 contain up to 5% by weight of one or more substantive dyes, preferred agents being at least one substantive dye included, the selected is from nitrophenylenediamines, nitroaminophenols, azo dyes, Anthraquinones or indophenols, preferably from the group of the international names or trade names known dyes HC Yellow 2, HC Yellow 4, HC Yellow 5, HC Yellow 6, HC Yellow 12, Acid Yellow 1, Acid Yellow 10, Acid Yellow 23, Acid Yellow 36, HC Orange 1, Disperse Orange 3, Acid Orange 7, HC Red 1, HC Red 3, HC Red 10, HC Red 11, HC Red 13, Acid Red 33, Acid Red 52, HC Red BN, Pigment Red 57: 1, HC Blue 2, HC Blue 12, Disperse Blue 3, Acid Blue 7, Acid Green 50, HC Violet 1, Disperse Violet 1, Disperse Violet 4, Acid Violet 43, Disperse Black 9, Acid Black 1, Acid Black 52, Basic Yellow 87, Basic Orange 31 and Basic Red 51 known compounds and 1,4-diamino-2-nitrobenzene, 2-amino-4-nitrophenol, 1,4-bis (β-hydroxyethyl) amino-2-nitrobenzene, 3-nitro-4- (β-hydroxyethyl) -aminophenol, 2- (2-hydroxyethyl) amino-4,6-dinitrophenol, 1- (2'-hydroxyethyl) amino-4-methyl-2-nitrobenzene, 1-Amino-4- (2-hydroxyethyl) amino-5-chloro-2-nitrobenzene, 4-amino-3-nitrophenol, 1- (2-ureidoethyl) amino-4-nitrobenzene, 4-amino-2-nitrodiphenylamine-2'-carboxylic acid, 6-nitro-1,2,3,4-tetrahydroquinoxaline, 2-hydroxy-1,4-naphthoquinone, picramic acid and its salts, 2-amino-6-chloro-4-nitrophenol, 4-ethylamino-3-nitrobenzoic acid and 2-chloro-6-ethylamino-1-hydroxy-4-nitrobenzene.

• – gewünschtenfalls ein Vorbehandlungsmittel M1 auf die Faser aufgebracht wird, dann
• – ein Mittel M2 auf der Faser zur Anwendung kommt, wobei gewünschtenfalls dem Mittel M2 vor der Anwendung ein weiteres Mittel M3 zugegeben wird,
• – dieses Mittel M2 nach einer Zeit von 5-45, vorzugsweise von 30-45 Minuten von der Faser abgespült wird
• – und nach der Behandlung gegebenenfalls ein Nachbehandlungsmittel M4 auf die Faser aufgetragen und nach einer Einwirkzeit von einigen Minuten wieder abgespült wird,

wobei mindestens eines der Mittel M1, M2 oder M3 ein erfindungsgemäßes Mittel ist.Another object of the present invention is a process for whitening keratin fibers, in particular human hair, in which

• - If desired, a pretreatment agent M1 is applied to the fiber, then
• A means M2 is applied to the fiber, wherein, if desired, an additional agent M3 is added to the agent M2 before use,
• - This agent M2 is rinsed from the fiber after a time of 5-45, preferably 30-45 minutes
• - and after the treatment optionally a post-treatment agent M4 applied to the fiber and rinsed again after a contact time of a few minutes,

wherein at least one of the means M1, M2 or M3 is an agent according to the invention.

Regarding further preferred embodiments the method according to the invention mutatis mutandis applies to the means of the invention said.

• – Verhinderung einer Verfärbung, insbesondere Grünverfärbung von blondem, gesträhntem oder blondiertem Haar und/oder
• – Behandlung einer insbesondere grün-stichigen Verfärbung von blondem, gesträhntem oder blondiertem Haar und/oder
• – Behandlung von dumpfen, matten, glanzlosen keratinischen Fasern und/oder
• – Verringerung der Sprödigkeit von keratinischen Fasern und/oder
• – Entziehen von Metallionen, insbesondere Kupferionen aus den keratinischen Fasern.

Another object of the present invention is the use of agents according to the invention

• Prevention of discoloration, in particular green discoloration of blond, streaked or bleached hair and / or
• - Treatment of a particular green-stained discoloration of blond, streaked or bleached hair and / or
• - Treatment of dull, dull, dull keratinic fibers and / or
• - Reduction of brittleness of keratinic fibers and / or
• - Removal of metal ions, in particular copper ions from the keratinic fibers.

Regarding further preferred embodiments the use according to the invention mutatis mutandis applies to the means of the invention said.

Claims (10)

Agents for the treatment of keratinic fibers, in particular human hair, having a pH of 2 to 5, preferably from 3 to 4, containing - based on its weight - 0.0005 to 5 wt .-% of one or more complexing agents from the groups of (i) esters of citric acid, (ii) esters of salicylic acid, (iii) aminopolycarboxylic acids, (iv) phosphonates and / or phosphates, (v) gluconates (vi) nitriloacetic acid and salts thereof. Composition according to Claim 1, characterized in that it contains 0.001 to 4 wt .-%, preferably 0.01 to 3 wt .-%, particularly preferably 0.1 to 2.5 wt .-%, more preferably 0.2 to 2 wt .-% and in particular 0.25 to 1.5 wt .-% of at least one complexing agent from the group - Citric acid trimethyl ester and or - citric acid triethyl ester and or - Citric acid tripropyl ester and or - Citric acid triisopropyl ester and or - Salicylic acid methyl ester and or - Salicylic acid ethyl ester and or - Salicylic acid propyl ester and or - salicylic acid isopropyl ester and or - nitrilotriacetic acid and / or - nitrilotriacetic acid trisodium salt and or - Nitrilotriacetic acid tripotassium salt and or - nitrilotriacetic acid triammonium salt and or Diethylenetriamine pentaacetic acid (DTPA) and or Β-alaninediacetic acid (β-ADA) and / or 1,3-propylenediaminetetraacetic acid (1,3-PDTA) and or Methylglycine diacetic acid (MGDA) and or - Nitriloacetic acid and / or - Nitriloacetic acid sodium salt and or - Nitriloacetic acid potassium salt and or - Nitriloacetic acid ammonium salt contains. Agent according to one of claims 1 or 2, characterized that it - related on his weight - 0.05 to 7.5% by weight, preferably 0.1 to 5% by weight, more preferably 0.2 to 3.5% by weight and in particular 0.25 to 2.5% by weight cationic (s) Polymer (s) containing preferred cationic polymer (s) being / are selected out - poly (methacryloyloxyethyltrimethylammonium chloride) (INCI: Polyquaternium-37) and / or; - quaternized cellulose derivatives (INCI: Polyquaternium 10) and / or Cationic alkylpolyglycosides and or - cationized Honey and / or - cationic Guar derivatives and / or - polymeric Dimethyldiallylammoniumsalzen and their copolymers with esters and Amides of acrylic acid and methacrylic acid and or - copolymers of vinylpyrrolidone with quaternized derivatives of dialkylaminoalkyl acrylate and methacrylate and / or - Vinylpyrrolidone-Vinylimidazoliummethochlorid copolymers and or - quaternized Polyvinyl alcohol and / or - Polyquaternium 2 and / or - Polyquaternium-7 and or - Polyquaternium 17 and / or - Polyquaternium 18 and / or - Polyquaternium 24 and / or - Polyquaternium 27 - cationic Silicones, in particular amodimethicones. Agent according to one of claims 1 to 3, characterized in that it additionally surfactant (s), preferably anionic (s) surfactant (s), more preferably fatty alcohol ether sulfates of the formula H ₃ C- (CH ₂ ) _n - (OCH ₂ CH ₂ ) _k -OSO ₃ ^- M ⁺ contains, in the n for values of 5 to 21, preferably from 7 to 19, particularly preferably from 9 to 17 and in particular from 11 to 13 and k for values of 1, 2, 3, 4 or 4, preferably for 2, and M is a cation from the group Na ⁺ , K ⁺ NH ₄ ⁺ , ½ Mg ²⁺ , ½ Zn ²⁺ , preferably Na ⁺ , where preferred means the surfactant (s) in amounts of 2 to 20 wt .-%, preferably from 5 to 15 wt .-% and in particular from 7.5 to 12 wt .-%, each based on the total agent, contain. Agent according to one of Claims 1 to 4, characterized in that it additionally contains amphoteric surfactant (s), preferably from the groups of - N-alkylglycines, - N-alkylpropionic acids, - N-alkylaminobutyric acids, - N-alkyliminodipropionic acids, N-hydroxyethyl-N-alkylamidopropylglycines, - N-alkyltaurines, - N-alkylsarcosines, - 2-alkylaminopropionic acids having in each case about 8 to 24 C atoms in the alkyl group, - alkylaminoacetic acids each having about 8 to 24 C atoms in the alkyl group, - N-cocoalkylaminopropionate, - cocoacylaminoethylaminopropionate - C ₁₂ -C ₁₈ -acylsarcosine, - N-alkyl-N, N-dimethylammonium glycinates, for example cocoalkyldimethylammonium glycinate, - N-acylaminopropyl-N, N-dimethylammoniumglycinate, for example cocoacylaminopropyl- dimethylammonium glycinate, - 2-alkyl-3-carboxymethyl-3-hydroxyethyl-imidazolines each having 8 to 18 carbon atoms in the alkyl or acyl group - Kokosacylaminoethylhydroxyethylcarboxymethylglycinat - d it contains compounds known under the INCI name cocamidopropyl betaine, - the compounds known by the INCI name Disodium Cocoamphodiacetate, preferred agents comprising the amphoteric surfactant (s) in amounts of from 1 to 15% by weight. , preferably from 2.5 to 12 wt .-% and in particular from 5 to 10 wt .-%, each based on the total agent included. Agent according to one of claims 1 to 5, characterized that it additionally Vitamins and / or pro-vitamins and / or vitamin precursors containing preferably assigned to groups A, B, C, E, F and H, preferred agents being in amounts of 0.1 to 5 wt .-%, preferably from 0.25 to 4 wt .-% and in particular from 0.5 to 2.5% by weight, based in each case on the total agent, contain. Agent according to one of claims 1 to 6, characterized that it additionally 0.05 to 5 wt .-%, preferably 0.1 to 2.5 wt .-%, particularly preferably 0.15 to 1% by weight and in particular 0.2 to 0.5% by weight of amino acid (s), preferably (an) amino acid (s) from the group glycine and / or alanine and / or valine and / or lysine and / or serine and / or proline and / or cysteine and / or leucine and / or threonine. Agent according to one of claims 1 to 8, characterized that it additionally - related on his weight - 0.001 to 5 wt .-% of one or more substantive dyes, wherein preferred agents contain at least one substantive dye, the selected is from nitrophenylenediamines, nitroaminophenols, azo dyes, Anthraquinones or indophenols, preferably from the group of known under international names or trade names Dyes HC Yellow 2, HC Yellow 4, HC Yellow 5, HC Yellow 6, HC Yellow 12, Acid Yellow 1, Acid Yellow 10, Acid Yellow 23, Acid Yellow 36, HC Orange 1, Disperse Orange 3, Acid Orange 7, HC Red 1, HC Red 3, HC Red 10, HC Red 11, HC Red 13, Acid Red 33, Acid Red 52, HC Red BN, Pigment Red 57: 1, HC Blue 2, HC Blue 12, Disperse Blue 3, Acid Blue 7, Acid Green 50, HC Violet 1, Disperse Violet 1, Disperse Violet 4, Acid Violet 43, Disperse Black 9, Acid Black 1, Acid Black 52, Basic Yellow 87, Basic Orange 31 and Basic Red 51 known Compounds as well as 1,4-diamino-2-nitrobenzene, 2-amino-4-nitrophenol, 1,4-bis (β-hydroxyethyl) amino-2-nitrobenzene, 3-nitro-4- (β-hydroxyethyl) -aminophenol, 2- (2-hydroxyethyl) amino-4,6-dinitrophenol, 1- (2'-hydroxyethyl) amino-4-methyl-2-nitrobenzene, 1-amino-4- (2-hydroxyethyl) amino-5-chloro-2-nitrobenzene, 4-amino-3-nitrophenol, 1- (2-Ureidoethyl) amino-4-nitrobenzene, 4-amino-2-nitrodiphenylamine-2'-carboxylic acid, 6-nitro-1,2,3,4-tetrahydroquinoxaline, 2-hydroxy-1,4-naphthoquinone, picramic and their salts, 2-amino-6-chloro-4-nitrophenol, 4-ethylamino-3-nitrobenzoic acid and 2-chloro-6-ethylamino-1-hydroxy-4-nitrobenzene. A process for whitening keratin fibers, in particular human hair, characterized in that If desired, a pretreatment agent M1 is applied to the fiber, then a means M2 is applied to the fiber, wherein if desired a further agent M3 is added to the agent M2 before application, this agent M2 after a period of 5-45, preferably rinsed from the fiber for 30-45 minutes - and after the treatment optionally a post-treatment agent M4 applied to the fiber and rinsed after a contact time of a few minutes, wherein at least one of the means M1, M2 or M3 means according to one of Claims 1 to 8 is. Use of agents according to one of claims 1 to 7 to - prevention a discoloration, especially green discoloration of blond, streaked or bleached hair and / or - Treatment of a particular green-eaten discoloration from blond, streaked or bleached hair and / or - treatment of dull, dull, lackluster keratin fibers and / or - Reduction of brittleness of keratinic fibers and / or - removing metal ions, in particular copper ions from the keratinic fibers.